US20210244892A1 - Tip Cap Assembly for Closing an Injection System - Google Patents
Tip Cap Assembly for Closing an Injection System Download PDFInfo
- Publication number
- US20210244892A1 US20210244892A1 US17/240,484 US202117240484A US2021244892A1 US 20210244892 A1 US20210244892 A1 US 20210244892A1 US 202117240484 A US202117240484 A US 202117240484A US 2021244892 A1 US2021244892 A1 US 2021244892A1
- Authority
- US
- United States
- Prior art keywords
- cap
- tip
- elastomeric inner
- rigid outer
- cap assembly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3202—Devices for protection of the needle before use, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5086—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile for indicating if defective, used, tampered with or unsterile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
Definitions
- the present invention generally relates to an injection system such as a syringe, as well as a tip cap assembly for securely closing the distal tip of the injection system.
- the distal end of a component or apparatus must be understood as meaning the end furthest from the hand of the user and the proximal end must be understood as meaning the end closest to the hand of the user, with reference to the injection system intended to be used with said component or apparatus.
- the distal direction must be understood as the direction of injection with reference to the injection system, and the proximal direction is the opposite direction, i.e. the direction towards the hand of the user.
- injection systems may include auto-injectors, medical pens or syringes.
- Conventional syringes are widely used because of their common availability, ease of use and limited cost. They usually comprise a longitudinal barrel with an open proximal end and a substantially closed distal end including a distally projecting tip.
- the fluid intended to be injected can be stored into the syringe barrel, and in this case, the open proximal end is closed by a stopper in sliding fluid-tight engagement within the barrel and actuated by a plunger rod.
- the tip is provided with a fluid passageway extending therethrough to allow the injection of the fluid when a distal pressure is applied on the plunger.
- the tip can be provided with an attached needle or can be of a luer type, meaning needle-free.
- Syringe barrels are typically made of glass or plastic. Glass is preferably chosen for its chemical neutrality and low gas permeability whereas plastic is preferably chosen for its resistance to shocks.
- a fluid can be a pharmaceutical solution such as a drug, a vaccine, vitamins or dietary minerals.
- Syringes are also useful to inject diagnostic solutions, cosmetic fluids, including gels such as hyaluronic acid or silicone compositions. The injection can be performed in every part of the body including skin, hypodermis, muscle and veins, depending on the application.
- syringes are provided empty and filled with a fluid immediately before the injection, but now syringes are more and more provided prefilled with the fluid to inject, ready to be used, leading to several advantages.
- prefilled syringes reduce the number of steps required to perform an injection, which is particularly valuable in emergency medicine.
- prefilled syringes reduce the risk of human error on the quantity or the quality of the fluid to be injected. Indeed, the administration of a wrong dose or undesired medicine may impede medical treatments efficacy and cause death or severe injuries on treated patients.
- prefilled syringes reduce the risk of contamination linked with the transfer of fluids from multidose vials into empty syringes, such contamination also leading to impede medical treatments efficacy.
- prefilled syringes are particularly useful to store fluids which are difficult to transfer. For example, it is appropriate to use such syringes when viscous liquids or gels are employed for cosmetic applications, or when pharmaceutical compositions are employed for anesthetic applications.
- needle-free syringes are equipped with a tip cap to close the distally extending tip.
- the injection system must be kept perfectly sealed during this period.
- the quality of the sealing between the tip cap and the syringe is very important as a deficient sealing could damage the nature or the purity of the fluids, leading to wastage of valuable fluids, potential unacceptable risks for the patients and potential unacceptable risks for the medical staff according to the nature of the pharmaceutical compositions stored inside the syringes.
- the syringe should be opened easily when required and the tip cap should be removed without excessive effort.
- sticking phenomenon can occur when a tip cap is plugged on the tip of a syringe. Indeed, it has been observed that when two materials are compressed together over an extended period of time, such phenomenon of sticking could occur and prevent a fast and easy opening of a prefilled syringe. Consequently, a tip cap difficult to open would lead to the rejection of the prefilled syringes before use and would constitute an unacceptable economic loss. This could also lead to the death or severe injury of patients requiring an immediate injection.
- the outside surface of the syringe tip needs to be preserved from contaminants, such as dust or micro-organisms, which could migrate from the tip to the fluid passageway. Indeed, if these contaminants are injected with the pharmaceutical fluid to a patient, it would trigger an inappropriate immune response, lessen the treatment efficacy and decrease the patient's trust into his treatment.
- a first aspect of the invention is a tip cap assembly adapted to close the fluid passageway of a distally projecting tip of an injection system, said tip cap assembly including:
- the contact between said elastomeric inner cap and the distally projecting tip is limited to the small distal surface of said tip.
- the proximal face of the elastomeric inner cap is essentially perpendicular to the rotational axis of the cone from which the frustoconical protrusion is derived.
- the surface of the proximal face may be flat or may show a slight curvature radius, the center of which being situated on said rotational axis.
- the diameter of the proximal face of the frustoconical protrusion of the elastomeric inner cap at least greater than the diameter of the fluid passageway does not allow the frustoconical protrusion to penetrate the fluid passageway of the distally projecting tip. This significantly reduces or cancels the sticking phenomenon that may happen after an extended period of storage and therefore allows a quick and easy removal of the tip cap assembly from the injection system.
- the proximal face of the frustoconical protrusion may be the most proximal face of the elastomeric inner cap.
- the elastomeric inner cap has globally the shape of a cylinder and the rigid outer cap has a globally tubular shape provided with a distal transversal wall.
- the elastomeric inner cap is received within the rigid outer cap so that the outer wall of the elastomeric inner cap is at least partially in contact with the inner wall of the rigid outer cap, in particular with the inner wall of a tubular part of the rigid outer cap.
- the elastomeric inner cap may be received with friction within the rigid outer cap.
- the elastomeric inner cap Due to its elastomeric nature, the elastomeric inner cap has the capability of being deformed when it is submitted to pressure, for example when a distal pressure is applied.
- a distal pressure For example, when the elastomeric inner cap has the global shape of a cylinder, it may be deformed radially outwardly under the effect of a longitudinal pressure, for example a distal pressure or a proximal pressure.
- the tip cap assembly is provided with stress-limiting means, also referred to as a stress-limiting element, allowing said elastomeric inner cap to be substantially deformed when the assembly closes said passageway, for example when a distal pressure is exerted on the elastomeric inner cap by the syringe tip.
- the stress-limiting means allow at least part of the elastomeric inner cap to be deformed radially outwardly, although the elastomeric inner cap is received within the rigid outer cap. The deformation of the elastomeric inner cap ensures an optimal sealing of the fluid passageway and the syringe tip.
- the rigid outer cap could be deformed by the stress transmitted by the elastomeric inner cap over an extended period of storage, and such deformed rigid cap might lead to a deficient sealing.
- the stress-limiting means avoids the unintended deformation of the rigid outer cap by limiting the amount of stress transmitted to the rigid outer cap by the deformation of the elastomeric inner cap when it closes said passageway, for example when distal pressure is exerted on the elastomeric inner cap, and contributes to maintain the optimal sealing over an extended period of time.
- these stress-limiting means include at least one window and more preferably two diametrically opposed longitudinal windows provided onto said rigid outer cap.
- the window(s) are provided on a tubular wall of the rigid outer cap.
- These windows accommodate the elastomeric material from the elastomeric inner cap resulting from the deformation caused by both the closing of the passageway and the insertion of the elastomeric cap into the rigid outer cap, for example when the diameter of the elastomeric cap is greater than the internal diameter of the rigid cap.
- the windows allow the elastomeric inner cap to be deformed radially outwardly.
- the window(s) may receive some part of the elastomeric inner cap which is deformed radially outwardly.
- these stress-limiting means further include a distal opening provided into said rigid outer cap to accommodate the distal deformation of the elastomeric inner cap when the tip cap assembly closes said the fluid passageway, for example when the elastomeric inner cap is submitted to distal pressure.
- the distal opening may be provided in the distal transversal wall of the rigid outer cap.
- the elastomeric cap and the outer rigid cap include holding means, also referred to as a holding element, intended to secure said elastomeric inner cap into said rigid outer cap.
- said holding means include a shoulder provided into the rigid outer cap and a radial rim provided onto the elastomeric inner cap, the elastomeric inner cap being proximally blocked by the contact between the distal rim and said shoulder.
- the shoulder and the radial rim therefore form proximal blocking means, also referred to as a proximal blocking element, for blocking the proximal movement of the elastomeric inner cap with respect to the rigid outer cap.
- said holding means further include at least one abutment surface provided into the rigid outer cap, and a distal face provided onto the elastomeric inner cap, said elastomeric inner cap being distally blocked by the contact between the abutment surface and the distal face.
- the abutment surface and the distal face therefore form distal blocking means, also referred to as a distal blocking element, for blocking the distal movement of the elastomeric inner cap with respect to the rigid outer cap.
- the shoulder, the radial rim, the abutment surface and the distal face form altogether locking means, also referred to as a locking arrangement, both in proximal and in distal translation of the elastomeric inner cap with respect to the rigid outer cap.
- the length L 1 defined between an abutment surface and the shoulder of the rigid outer cap is greater than the length L 2 defined between the distal face and the radial rim of said elastomeric inner cap, L 1 and L 2 being measured along a longitudinal axis of the tip cap assembly.
- a gap is therefore left between the rigid outer cap and the elastomeric inner cap: the presence of such a gap simplifies the assembling of the tip cap assembly and allows an optimal and sustainable closure, even with non-standard syringes.
- a second aspect of the disclosure is an injection system including a longitudinal barrel, a distally projecting tip provided with a fluid passageway extending therethrough, a distal surface and a lateral surface, where the injection system further includes a tip cap assembly according to the first aspect of the disclosure.
- a third aspect of the disclosure is an injection system including a longitudinal barrel having a distally projecting tip and a tip cap assembly, said distally projecting tip being provided with a fluid passageway extending therethrough, a distal surface and a lateral surface, said tip cap assembly including an elastomeric inner cap including a frustoconical protrusion and a rigid outer cap which can be securely disposed around said elastomeric inner cap, said assembly being configured so that, when said tip cap assembly closes said passageway, said frustoconical protrusion contacts said distally projecting tip only at the distal surface.
- the rigid outer cap is provided with a sterility skirt intended for a circumferential sealing of the lateral surface of said distally projecting tip when said assembly closes said fluid passageway.
- This sterility skirt maintains sterile the distal tip of the syringe during storage and thus the content of the injection system.
- the sterility skirt is further provided with at least one annular ridge.
- the annular ridge is provided on the inner wall of the sterility skirt.
- the at least one annular ridge may enhance the sealing provided between the sterility skirt and the lateral surface of the distally projecting tip.
- the injection system is provided with a collar securely engaged around said distal tip, having an inner thread and a distal rim, and wherein said rigid outer cap is provided with an outer thread able to cooperate with the thread of the collar to close said passageway.
- the rigid outer cap is provided with a proximal abutment surface contacting the distal rim of the collar when said tip cap assembly closes said passageway.
- a fourth aspect of the disclosure is a tip cap assembly adapted to close the fluid passageway of the distally projecting tip of an injection system.
- the tip cap assembly includes an elastomeric inner cap having a distal portion and a proximal portion and a rigid outer cap adapted to be securely disposed around the elastomeric inner cap.
- the proximal portion of the elastomeric inner cap includes a frustoconical protrusion and a proximal face having a diameter greater than the diameter of the fluid passageway of the injection system.
- the tip cap assembly further includes a stress-limiting means to accommodate deformation of the elastomeric inner cap when the assembly closes the fluid passageway.
- the stress-limiting means may include at least one window in the rigid outer cap and, preferably, two diametrically opposed longitudinal windows.
- the stress-limiting means may include a distal opening in the rigid outer cap.
- the elastomeric cap and the outer rigid cap each include at least one engagement surface, wherein contact of the engagement surface of the elastomeric inner cap with the engagement surface of the rigid outer cap secures the elastomeric inner cap to the rigid outer cap.
- the engagement surface of the rigid outer cap may include a shoulder, and the engagement surface of the elastomeric inner cap may include a radial rim, wherein the radial rim contacts the shoulder at least when a proximal pressure is applied to the elastomeric inner cap.
- the engagement surface of the rigid outer cap may include at least one abutment surface
- the engagement surface of the elastomeric inner cap may include a distal face, wherein the at least one abutment surface contacts the distal face at least when a distal pressure is applied to the elastomeric inner cap.
- the length L 1 defined between the abutment surface and the shoulder of the rigid outer cap may be greater than the length L 2 defined between the distal face and the radial rim of the elastomeric inner cap.
- the outer rigid cap may include a distal portion, a central portion, and a proximal portion.
- the at least one stress-limiting means preferably a longitudinal window, may be located in the distal portion of the outer rigid cap and the proximal section may have a frustoconical shape.
- the outer rigid cap may further include internal and/or external reinforcement means, also referred to as reinforcement elements.
- the reinforcement means may be longitudinal or circumferential ribs.
- the elastomeric inner cap may include a distal portion and a proximal portion.
- the distal portion may be essentially cylindrical with a flat distal face and the proximal portion may comprise a frustoconical protrusion.
- the diameter of the proximal portion may be less than the diameter of the distal portion.
- the proximal portion of the elastomeric inner cap may also include a circular bump.
- the elastomeric cap may adopt three different configurations: a free configuration when it is not assembled with the rigid cap, a first stressed configuration when it is assembled into the rigid cap to form the tip cap assembly and a second stressed configuration due to the distal pressure applied by the distally projecting tip when the tip cap assembly closes the fluid passageway of an injection system.
- the distal end of the elastomeric inner cap is received in the distal portion of the outer rigid cap and the proximal portion of the elastomeric inner cap is received in the central portion of the outer rigid cap.
- the outside diameter of the distal portion of the elastomeric inner cap may be greater than the inside diameter of the distal portion of the outer rigid cap and/or the outside diameter of the proximal portion of the elastomeric inner cap may be greater than the inside diameter of the central portion of the outer rigid cap in order to enhance contact between the engagement surfaces of the outer rigid cap and the elastomeric inner cap.
- the elastomeric inner cap is further compressed between the rigid inner cap and the distally projecting tip of the injection system.
- the stress-limiting means acts to reduce the stress placed on the rigid outer cap due to the compression of the elastomeric inner cap.
- a fifth aspect of the disclosure is an injection system including a longitudinal barrel, and a distally projecting tip having a fluid passageway extending therethrough, a distal surface, and a lateral surface, wherein the injection system further includes a tip cap assembly as described above.
- the frustoconical protrusion when the tip cap assembly closes the fluid passageway, the frustoconical protrusion only contacts the distal surface of the distally projecting tip.
- the rigid outer cap may further include a sterility skirt that provides a circumferential seal between the lateral surface of the distally projecting tip and the rigid outer cap when the tip cap assembly closes the passageway.
- the sterility skirt may include at least one annular ridge.
- the injection system may further include a collar securely engaged around the distal tip.
- the collar may have an inner thread and a distal rim.
- the rigid outer cap includes an outer thread adapted to cooperate with the inner thread of the collar in order to close the passageway.
- the rigid outer cap may further include a proximal abutment surface that contacts the distal rim of the collar when the tip cap assembly closes the passageway. This engagement of the proximal abutment surface and the distal rim of the collar prevents rotational movement of the tip with respect to the injection system to avoid damage to the tip cap assembly and assures correct positioning of the tip cap with regard to the collar to signal the user that a seal has been formed.
- a sixth aspect of the disclosure is an injection system including a longitudinal barrel, a distally projecting tip and a collar provided with an inner thread.
- the collar is securely engaged around the distally projecting tip and the distally projecting tip has a lateral surface and a fluid passageway extending therethrough.
- the injection system further includes a tip-cap assembly including an elastomeric inner cap and a rigid outer cap that is or can be securely disposed around the elastomeric inner cap.
- the rigid outer cap of the tip cap assembly includes an outer thread intended to be screwed with the inner thread of the collar, a frustoconical extension and a radial recess between the outer thread and the frustoconical extension.
- the frustoconical extension is intended to ensure a circumferential sealing of the distally projecting tip around the lateral surface in order to act as a sterility skirt when the tip-cap assembly closes the passageway of the projecting tip.
- the frustoconical extension of the rigid outer cap may be provided with at least one annular ridge, preferably three.
- a seventh aspect of the disclosure is a tip-cap assembly adapted to close the fluid passageway of the distally projecting tip of an injection system.
- the tip-cap assembly includes an elastomeric inner cap which has a distal face and a radial rim, and a length L 2 defined as the distance between the distal face and the radial rim.
- the tip-cap assembly further includes a rigid outer cap which is or can be securely disposed around the elastomeric inner cap, with a shoulder and at least one abutment surface, and a length L 1 defined as the distance between the at least one abutment surface and the shoulder.
- the elastomeric inner cap is distally blocked by the contact between the distal face and the at least one abutment surface, and proximally blocked by the contact between the radial rim and the shoulder.
- the length L 1 is greater than the length L 2 in order to allow a limited translation of the elastomeric inner cap within the rigid outer cap.
- FIG. 1A is a side view of a syringe without a tip cap
- FIG. 1B is a perspective view of a syringe without a tip cap
- FIG. 1C is a cross-section view of a syringe without a tip cap
- FIG. 2A is a side view of the syringe of FIGS. 1A-1C closed by a tip cap assembly of an abstract of the present disclosure
- FIG. 2B is a perspective view of the syringe of FIGS. 1A-1C closed by a tip cap assembly of an aspect of the present disclosure
- FIG. 2C is a cross-section view of the syringe of FIGS. 1A-1C closed by a tip cap assembly of an aspect of the present disclosure
- FIG. 3A is a side view of the rigid outer cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 3B is a cross-section view of the rigid outer cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 3C is another cross-section view of the rigid outer cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 3D is a perspective view of the rigid outer cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 3E is a cross-section perspective view of the rigid outer cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 4A is a side view of the elastomeric inner cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 4B is a perspective view of the elastomeric inner cap of the tip cap assembly of FIGS. 2A and 2B ;
- FIG. 5 is the theoretical superimposition of the rigid outer cap of FIGS. 3A, 3B and 3C on the elastomeric inner cap of FIGS. 4A and 4B ;
- FIG. 6A is a cross-section view of a tip cap assembly according to an aspect of the present disclosure.
- FIG. 6B is a cross-section view of a tip cap assembly according to another aspect of the present disclosure.
- FIG. 7 is a cross-section view of a tip cap assembly mounted on the syringe of FIGS. 1A, 1B and 1C ;
- FIG. 8 is a perspective view of the syringe of FIGS. 1A-1C closed by a tip cap assembly according to an aspect of the present disclosure.
- FIG. 9 is a perspective view of the syringes of FIGS. 1A-1C closed by a tip cap assembly according to another aspect of the present disclosure.
- FIGS. 1A-1C show an injection system 10 in the form of a luer syringe according to an aspect of the disclosure.
- the present disclosure could be used with any other types of injection systems, such as a pen, or an infusion system, provided they include a distally projecting tip.
- the syringe 10 includes a longitudinal barrel 11 having a longitudinal axis A, a proximal flange 12 and a distally projecting tip 13 .
- the distally projecting tip 13 includes a fluid passageway 14 extending therethrough, a distal surface 15 and a lateral surface 16 (see FIG. 1C ) which is substantially tubular.
- a collar 20 is securely engaged around the tip 13 , for example by clipping, screwing or welding.
- the collar 20 is molded with the longitudinal barrel with which it forms only one part.
- the collar 20 is provided with an inner thread 21 and a distal rim 22 .
- the syringe 10 is further provided with a stopper and a plunger rod, not shown in FIGS. 1A-1C .
- the syringe 10 may be sealingly closed by a tip cap assembly 30 .
- This tip cap assembly 30 includes a rigid outer cap 40 which receives an elastomeric inner cap 50 .
- the rigid outer cap 40 will now be described with references to FIGS. 3A-3E .
- the rigid outer cap 40 includes an essentially tubular wall 41 having a longitudinal axis A′ and defining a cavity 41 a open on both distal and proximal ends.
- the tubular wall 41 includes three different portions: a distal portion 42 , a central portion 43 and a proximal portion 44 .
- the distal portion 42 has an essentially tubular shape and includes a distal opening 42 a and two longitudinal windows 42 b (see FIG. 3E , only one visible in FIGS. 3A and 3B ), diametrically opposed, in the example shown.
- Each window 42 b is enclosed on its outside by two longitudinal ribs 42 c and one distal radial rib 42 d and on its inside by two abutment surfaces 42 e and a shoulder 42 f.
- one, three or four abutment surfaces 42 e are provided into the rigid cap 40 .
- a length L 1 measured along axis A′, is defined between the abutment surfaces 42 e and the shoulder 42 f and consists in the longitudinal dimension of the longitudinal windows 42 b.
- the shoulder 42 f is located between the distal portion 42 and the central portion 43 .
- the distal portion 42 includes one, three or four windows 42 b.
- the central portion 43 has an essentially tubular shape and includes on the inside a plurality of longitudinal rims 43 a linked with a shoulder 43 b. On the outside, a ring 43 c including a proximal abutment surface 43 d is linked with two longitudinal ribs 43 e and the longitudinal ribs 42 c.
- the longitudinal ribs 43 e only extend along part of the central portion 43 while the longitudinal ribs 42 c, enclosing the windows 42 b, extend along both the distal portion 42 and part of the central portion 43 .
- the shoulder 43 b is located between the central portion 43 and the proximal portion 44 .
- the proximal portion 44 has an extension having the shape of a truncated cone or frustoconical extension 44 a.
- the frustoconical extension 44 a includes a proximal opening 44 b and three annular ridges 44 c.
- an outer thread 44 d extends from the ring 43 c of the central portion 43 and is separated from the frustoconical extension 44 a by a radial recess 44 e.
- the rigid cap 40 is not provided with an outer thread 44 d and the proximal portion 44 only includes a frustoconical extension 44 a with ridges 44 c. This aspect can then be used with a syringe 10 that is not provided with a collar 20 .
- the rigid outer cap can be made of a rigid polymer such as polypropylene, polyethylene, polyvinylchloride, polystyrene, polycarbonate or a copolymer such as acrylonitrile butadiene styrene or styrene acrylonitrile.
- a rigid polymer such as polypropylene, polyethylene, polyvinylchloride, polystyrene, polycarbonate or a copolymer such as acrylonitrile butadiene styrene or styrene acrylonitrile.
- the elastomeric inner cap 50 includes a distal portion 51 and a proximal portion 52 both having a longitudinal axis A′′.
- the distal portion 51 has an essentially cylindrical shape and a flat distal face 53 .
- the proximal portion 52 includes a frustoconical protrusion 54 having the shape of a truncated cone, a proximal face 55 essentially perpendicular to the axis A′′ and a circular bump 56 .
- the proximal portion 52 has a smaller average diameter than the distal portion 51 and a radial rim 57 is located at the connection between the proximal portion 52 and the distal portion 51 .
- the cone angle a of the truncated cone forming the frustoconical protrusion 54 ranges from 40° to 60° relative to axis A′′, more preferably is 50° relative to axis A′′.
- the length L 2 of the distal portion 51 is defined between the radial rim 57 and the flat distal face 53 .
- the proximal face 55 is essentially flat. In other aspects (not shown), the proximal face 55 has a curvature radius, the center of which being situated on the axis A′′.
- the diameter of the proximal face 55 is preferably greater than the diameter of the fluid passageway 14 of the distal tip 13 . As appears from FIGS. 4A and 4B , the proximal face 55 is the most proximal face of the elastomeric inner cap 50 .
- the elastomeric cap 50 is able to adopt three different configurations: a free configuration when it is not assembled with the rigid cap 40 , a first stressed configuration when it is assembled into the rigid cap 40 to form the tip cap assembly 30 and a second stressed configuration due to the distal pressure applied by the distally projecting tip 13 when the tip cap assembly 30 closes the fluid passageway 14 of an injection system 10 , as will be explained later.
- Suitable materials for the elastomeric cap 50 of the invention include natural rubber, acrylate-butadiene rubber, cis-polybutadiene, chloro or bromobutyl rubber, chlorinated polyethylene elastomers, polyalkylene oxide polymers, ethylene vinyl acetate, fluorosilicone rubbers, hexafluoropropylene-vinylidene fluoride-tetrafluoroethylene terpolymers, butyl rubbers, polyisobutene, synthetic polyisoprene rubber, silicone rubbers, styrene-butadiene rubbers, tetrafluoroethylene propylene copolymers, thermoplastic-copolyesters, thermo-plastic elastomers, or the like or a combination thereof.
- FIG. 5 The superposition of cross-sectional views of the elastomeric inner cap 50 ( FIGS. 4A-4B ) and the rigid outer cap 40 ( FIGS. 3A-3E ) is shown as a theoretical view in FIG. 5 , as the represented shape of the elastomeric inner cap 50 on this Figure is that of its free configuration and therefore overlaps (at circular bump 56 ) the shape of the rigid outer cap 40 .
- the distal portion 51 of the elastomeric inner cap 50 is intended to be received in the distal portion 42 of the rigid cap 40
- the proximal portion 52 of the elastomeric inner cap 50 is intended to be received in the central portion 43 of the rigid cap 40 .
- FIG. 5 The superposition of cross-sectional views of the elastomeric inner cap 50 ( FIGS. 4A-4B ) and the rigid outer cap 40 ( FIGS. 3A-3E ) is shown as a theoretical view in FIG. 5 , as the represented shape of the elastomeric inner cap 50 on this Figure
- the axis A′ of the rigid cap 40 is superposed with the axis A′′ of the elastomeric inner cap 50 and the length L 1 included between the abutment surface 42 e and the shoulder 42 f is slightly greater than the length L 2 of the distal portion 51 of the elastomeric inner cap 50 .
- the length L 1 is equal to the length L 2 of the distal portion 51 .
- the length L 1 is slightly smaller in comparison to the length L 2 .
- the circular bump 56 of the elastomeric inner cap 50 has a diameter slightly greater than the internal diameter of the central portion 43 of the rigid cap 40 .
- FIGS. 6A and 6B A tip cap assembly 30 ready to be used, with the elastomeric inner cap 50 assembled into the rigid cap 40 , is shown in FIGS. 6A and 6B .
- the elastomeric inner cap 50 is maintained inside the rigid cap 40 and is in its first stressed configuration: its distal portion 51 is enclosed between the abutment surface 42 e and the shoulder 42 f of the rigid cap 40 and its longitudinal axis A′′ is superposed with the longitudinal axis A′ of the rigid cap 40 .
- the elastomeric inner cap 50 is distally blocked by the contact between its distal face 53 and the abutment surfaces 42 e of the rigid cap 40 , and proximally blocked by the contact between its radial rim 57 and the shoulder 42 f of the rigid cap 40 .
- the length L 1 is greater than the length L 2 and a gap G exists between the rigid cap 40 and the elastomeric cap 50 which allows a limited translation of the elastomeric cap 50 within the rigid cap 40 .
- the abutment surfaces 42 e of the rigid cap 40 contact directly the distal face 53 of the elastomeric inner cap 50 while the shoulder 42 f of the rigid cap 40 contacts the radial rim 57 of the elastomeric cap 50 .
- the radial rim 57 contacts the shoulder 42 f at least when a proximal pressure is applied on the elastomeric inner cap 50
- the abutment surfaces 42 e contact the distal face 53 at least when a distal pressure is applied on the elastomeric inner cap 50
- the abutment surfaces 42 e and the shoulder 42 f of the rigid cap 40 together with the distal face 53 and the radial rim 57 therefore form holding means to secure the elastomeric inner cap 50 within the rigid cap 40 .
- the average diameter of the distal portion 51 of the elastomeric inner cap 50 is chosen to be slightly larger than the inside diameter of the distal portion 42 of the rigid cap 40 .
- the elastomeric inner cap 50 is tightened on its diameter, is slightly deformed, and part of this elastomeric inner cap 50 even protrudes further through the windows 42 b of the rigid cap 40 when assembled (as shown in FIG. 7 ). This deformation thus enhances the contact area between the abutments surfaces 42 e and the distal face 53 of the elastomeric inner cap 50 .
- FIG. 7 shows that enhances the contact area between the abutments surfaces 42 e and the distal face 53 of the elastomeric inner cap 50 .
- the circular bump 56 of the proximal portion 52 has a diameter slightly larger than the inside diameter of the central portion 43 of the rigid cap 40 . Consequently, the proximal portion 52 is tightened on its whole diameter, and the frustoconical protrusion 54 is deformed over its length, thus further extending toward the proximal portion 44 of the rigid cap 40 . These deformations further contribute to maintain the elastomeric inner cap 50 in the rigid cap 40 . In the aspect where L 1 is smaller than L 2 (not shown), the distal portion 51 of the elastomeric cap 50 is tightened on its length and slightly deformed.
- the assembly of the tip cap 30 can be obtained by aligning the axis A′ of the rigid cap 40 with the axis A′′ of the elastomeric inner cap 50 , the proximal portion 52 of the elastomeric inner cap 50 facing the distal opening 42 a of the rigid cap 40 .
- a proximal pressure applied on the elastomeric inner cap 50 , or a distal pressure applied on the rigid cap 40 allows the introduction and the slight deformation of the elastomeric inner cap 50 into the rigid cap 40 .
- the gap G leads to a simpler assembling by allowing a greater deformation of the elastomeric cap 50 and permitting to have higher ranges of manufacturing tolerances.
- the tip cap assembly 30 of the present aspect is therefore very fast to assemble and the probability of an incorrect assembling is very limited.
- the tip cap assembly 30 is now ready to be connected with a syringe 10 as shown in FIG. 7 .
- the axis A′, A′′ of the tip cap assembly are aligned with the axis A of the syringe 10 , the proximal opening 44 b of the tip cap assembly 30 facing the distally projecting tip 13 of the syringe 10 .
- the tip cap assembly 30 is provided with an outer thread 44 d, a rotational movement is required to screw the outer thread 44 d into the inner thread 21 of the collar 20 of the syringe 10 .
- the projecting tip 13 comes in contact with the proximal face 55 of the elastomeric inner cap 50 .
- the elastomeric cap 50 is pushed against the abutment surfaces 42 e of the rigid cap 40 and then progressively compressed.
- the elastomeric cap 50 is already immobilized inside the rigid cap 40 and is directly compressed by the projecting tip 13 . Thereafter, the lateral surface 16 of the projecting tip 13 comes in contact with the frustoconical extension 44 a, which is progressively deformed radially outwardly.
- the proximal abutment surface 43 d of the tip cap assembly 30 comes in contact with the distal rim 22 of the collar 20 .
- the tip cap assembly 30 is secured to the collar 20 and to the distally projecting tip 13 as shown in FIGS. 2A, 2B and 7 .
- the proximal abutment surface 43 d of the rigid cap 40 cooperates with the distal rim 22 of the collar 20 to prevent any further rotational movement that would damage the tip cap assembly 30 .
- This cooperation also ensures the correct positioning of the tip cap 30 with respect to the collar 20 and provides the user with a tactile indication that the syringe 10 is hermetically sealed.
- the proximal abutment surface 43 d is not present on the ring 43 c but integrated on the outer surface of the rigid cap 40 .
- the tip cap assembly 30 is simply mounted on the distally projecting tip 13 by a proximal movement.
- the elastomeric inner cap 50 does not substantially penetrate the fluid passageway 14 since the diameter of the proximal face 55 is at least greater than the diameter of the fluid passageway 14 .
- the elastomeric inner cap 50 is compressed between the distally projecting tip 13 and the abutment surfaces 42 e of the rigid cap 40 , which significantly deforms the proximal portion 52 of the elastomeric inner cap 50 in order to ensure the tight sealing of the fluid passageway 14 .
- Part of this deformation is absorbed by the specific shape of the frustoconical protrusion 54 of the elastomeric cap 50 , which contributes to limit both axial and radial stress transmitted to the rigid cap 40 .
- the deformation of the elastomeric cap 50 is also partially allowed by the distal opening 42 a and the longitudinal windows 42 b of the rigid cap 40 , as shown in FIG. 7 , further reducing the amount of axial stress transmitted to the rigid cap 40 through the abutment surfaces 42 e.
- the frustoconical protrusion 54 of the elastomeric inner cap 50 as well as the distal opening 42 a and the longitudinal windows 42 b of the rigid cap 40 therefore constitute stress-limiting means that allow the elastomeric cap 50 to be substantially deformed when the tip cap assembly 30 closes the passageway 14 of the syringe 10 .
- Unintended deformation of the rigid cap 40 and in particular of its distal portion 42 due to the stress resulting of the compression of the elastomeric cap 50 over time, is therefore avoided: the syringe can be kept perfectly sealed during storage time.
- the rigid cap 40 is reinforced on its outside by the longitudinal ribs 43 e, the longitudinal ribs 42 c and the distal radial ribs 42 d and on its inside by the longitudinal rims 43 a and the shoulder 43 b, in order to resist against any deformation that might result from the stress transmitted by the elastomeric inner cap 50 when the tip cap assembly 30 closes the fluid passageway 14 , or by the user while manipulating the tip cap assembly.
- Longitudinal ribs 43 e, the longitudinal ribs 42 c, the distal radial ribs 42 d, the longitudinal rims 43 a and the shoulder 43 b therefore constitute reinforcement means.
- the gap G between the rigid cap 40 and the elastomeric cap 50 is also useful to be compatible with different kinds of syringes showing unconventional lengths of distally projecting tip 13 , for example syringes that have not been designed according to usual standards.
- the tip cap assembly 30 according to this specific aspect can provide an optimal and sustainable sealing even in the case of non-standard syringes.
- the radial recess 44 e allows a limited radial deformation of the frustoconical extension 44 a due to the contact with the lateral surface 16 of the distally projecting tip 13 .
- the frustoconical extension 44 a extends around and hermetically seals the distally projecting tip 13 , the three annular ridges 44 c being in tight contact with its lateral surface 16 . This ensures the circumferential sealing of the lateral wall 16 of the distal tip 13 and allows the sterile maintenance of the cavity 41 a of the tip cap assembly 30 and therefore the projecting tip 13 of the syringe 10 .
- the circumferential sealing of the lateral wall 16 of the distal tip 13 is performed even when the distal tip 13 is not perfectly circular.
- a distal tip 13 showing a limited asymmetry or a ellipsoidal section resulting of manufacturing tolerances does not deteriorate the sterility of the cavity 41 a of the tip cap assembly 30 .
- the frustoconical extension 44 a therefore acts as a sterility skirt during the storage time of a prefilled syringe and significantly limits or eliminates migration of contaminants from the projecting tip to the fluid before and during the step of injection to a patient.
- the sterility skirt 44 a is provided with at least one annular ridge 44 c.
- the specific shape of the frustoconical protrusion 54 of the tip cap assembly 30 limits the area of contact between the elastomeric cap 50 and the distally extending tip 13 to the distal surface 15 , therefore avoiding any contact between the elastomeric inner cap 50 and the lateral surface 16 or the fluid passageway 14 of the distally extending tip 13 . This significantly reduces or cancels the sticking phenomenon that may happen after an extended storage period and therefore allows a quick and easy removal of the tip cap assembly 30 .
- the fluid passageway 14 is also maintained clean of particles since the frustoconical protrusion 54 does not contact directly the inside surface of the fluid passageway 14 .
- the frustoconical protrusion 54 of the elastomeric inner cap 50 also creates a spring effect to the tip cap assembly 30 which further contributes to an easy removal.
- reinforcement means 43 e, 42 c, 42 d, 43 a and 43 b allow for a thinner tubular wall 41 of the rigid cap 40 .
- the deformation of the rigid cap 40 during the removal step is therefore limited, which again ensures an easy removal.
- the tip cap assembly according to the present disclosure therefore can reduce economic loss by preventing discarding prefilled syringes before use.
- injection can be done at very short notice and without excessive effort. This could save patients requiring immediate treatment.
- the tip cap assembly 100 has the global shape of an elliptic cylinder and includes elliptical reinforcement ridges 141 and 142 on the outer surface of the rigid cap 140 , the proximal portion (not visible) of the rigid cap 140 being substantially cylindrical to fit within the syringe collar 20 and all other features being similar to those previously described for the tip cap assembly 30 of FIGS. 1-7 . Comparing to the circular cylinder tip cap assembly 30 , the tip cap assembly 100 is easier to screw or remove from the syringe collar 20 as the elliptical shape provides more contact surface to the user's fingers, leading to a better gripping ability.
- the tip cap assembly 200 has globally the shape of an elliptical cylinder and the outer surface of the rigid cap 240 is provided with longitudinal reinforcement ridges 241 surrounding the windows 242 (only one visible in FIG. 9 ), and two flat surfaces 243 placed between the windows 242 .
- the proximal portion (not visible) of the rigid cap 240 is substantially cylindrical to fit within the syringe collar 20 and all other features are similar to those previously described for the tip cap assembly 30 of FIGS. 1-7 . Comparing to the circular cylinder tip cap assembly 30 , the tip cap assembly 200 is easier to screw or remove from the syringe collar 20 as the elliptical shape provides more contact surface to the user's fingers, leading to a better gripping ability.
- the tip cap assembly 30 can be provided with a tamper evidence feature, for example in the form of breakable tabs between the collar 20 and the ring 43 c of the rigid cap 40 .
- the tamper evidence features also include a security ring provided on the collar 20 .
- the tip cap assemblies according to the present disclosure allows maintaining a perfect sealing overtime, protecting the syringe tip from contamination during storage time and providing an opening with limited effort.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 15/028,950 filed Apr. 13, 2016, which is the United States national phase of International Application No. PCT/EP2014/071950 filed Oct. 14, 2014, and claims priority to European Patent Application No. 13306414.7 filed Oct. 15, 2013, the disclosures of each of which are hereby incorporated in their entirety by reference.
- The present invention generally relates to an injection system such as a syringe, as well as a tip cap assembly for securely closing the distal tip of the injection system.
- In this application, the distal end of a component or apparatus must be understood as meaning the end furthest from the hand of the user and the proximal end must be understood as meaning the end closest to the hand of the user, with reference to the injection system intended to be used with said component or apparatus. As such, in this application, the distal direction must be understood as the direction of injection with reference to the injection system, and the proximal direction is the opposite direction, i.e. the direction towards the hand of the user.
- Current medicine uses a wide range of injection systems to deliver fluids into the body of patients. For example, such injection systems may include auto-injectors, medical pens or syringes. Conventional syringes are widely used because of their common availability, ease of use and limited cost. They usually comprise a longitudinal barrel with an open proximal end and a substantially closed distal end including a distally projecting tip. The fluid intended to be injected can be stored into the syringe barrel, and in this case, the open proximal end is closed by a stopper in sliding fluid-tight engagement within the barrel and actuated by a plunger rod. The tip is provided with a fluid passageway extending therethrough to allow the injection of the fluid when a distal pressure is applied on the plunger. The tip can be provided with an attached needle or can be of a luer type, meaning needle-free. Syringe barrels are typically made of glass or plastic. Glass is preferably chosen for its chemical neutrality and low gas permeability whereas plastic is preferably chosen for its resistance to shocks.
- Almost all fluids can be injected with a syringe. For example, a fluid can be a pharmaceutical solution such as a drug, a vaccine, vitamins or dietary minerals. Syringes are also useful to inject diagnostic solutions, cosmetic fluids, including gels such as hyaluronic acid or silicone compositions. The injection can be performed in every part of the body including skin, hypodermis, muscle and veins, depending on the application.
- Usually, syringes are provided empty and filled with a fluid immediately before the injection, but now syringes are more and more provided prefilled with the fluid to inject, ready to be used, leading to several advantages. First of all, prefilled syringes reduce the number of steps required to perform an injection, which is particularly valuable in emergency medicine. Furthermore, prefilled syringes reduce the risk of human error on the quantity or the quality of the fluid to be injected. Indeed, the administration of a wrong dose or undesired medicine may impede medical treatments efficacy and cause death or severe injuries on treated patients. Additionally, prefilled syringes reduce the risk of contamination linked with the transfer of fluids from multidose vials into empty syringes, such contamination also leading to impede medical treatments efficacy. Finally, prefilled syringes are particularly useful to store fluids which are difficult to transfer. For example, it is appropriate to use such syringes when viscous liquids or gels are employed for cosmetic applications, or when pharmaceutical compositions are employed for anesthetic applications.
- During the time between the filling of the syringe and its use, needle-free syringes are equipped with a tip cap to close the distally extending tip. Indeed, as fluids are stored in the prefilled syringe for an extended period of time, typically from 6 to 18 months before injection, the injection system must be kept perfectly sealed during this period. The quality of the sealing between the tip cap and the syringe is very important as a deficient sealing could damage the nature or the purity of the fluids, leading to wastage of valuable fluids, potential unacceptable risks for the patients and potential unacceptable risks for the medical staff according to the nature of the pharmaceutical compositions stored inside the syringes.
- Moreover, the syringe should be opened easily when required and the tip cap should be removed without excessive effort. But it is well known that sticking phenomenon can occur when a tip cap is plugged on the tip of a syringe. Indeed, it has been observed that when two materials are compressed together over an extended period of time, such phenomenon of sticking could occur and prevent a fast and easy opening of a prefilled syringe. Consequently, a tip cap difficult to open would lead to the rejection of the prefilled syringes before use and would constitute an unacceptable economic loss. This could also lead to the death or severe injury of patients requiring an immediate injection.
- Finally, the outside surface of the syringe tip needs to be preserved from contaminants, such as dust or micro-organisms, which could migrate from the tip to the fluid passageway. Indeed, if these contaminants are injected with the pharmaceutical fluid to a patient, it would trigger an inappropriate immune response, lessen the treatment efficacy and decrease the patient's trust into his treatment.
- Therefore, it is an object of the invention to provide a tip cap ensuring an improved and sustainable sealing of the syringe tip. It is further an object of the invention to provide a tip cap that can be easily unplugged from the syringe tip. It is another object of the invention to maintain the syringe tip sterility during storage.
- A first aspect of the invention is a tip cap assembly adapted to close the fluid passageway of a distally projecting tip of an injection system, said tip cap assembly including:
-
- an elastomeric inner cap having a frustoconical protrusion extending proximally, said frustoconical protrusion having a proximal face, and
- a rigid outer cap which is or can be securely disposed around said elastomeric inner cap, the proximal face of the frustoconical protrusion having a diameter at least greater than the diameter of the fluid passageway of the injection system.
- Due to the frustoconical protrusion of the elastomeric inner cap, the contact between said elastomeric inner cap and the distally projecting tip is limited to the small distal surface of said tip. Indeed, the proximal face of the elastomeric inner cap is essentially perpendicular to the rotational axis of the cone from which the frustoconical protrusion is derived. The surface of the proximal face may be flat or may show a slight curvature radius, the center of which being situated on said rotational axis. Moreover, the diameter of the proximal face of the frustoconical protrusion of the elastomeric inner cap at least greater than the diameter of the fluid passageway does not allow the frustoconical protrusion to penetrate the fluid passageway of the distally projecting tip. This significantly reduces or cancels the sticking phenomenon that may happen after an extended period of storage and therefore allows a quick and easy removal of the tip cap assembly from the injection system. The proximal face of the frustoconical protrusion may be the most proximal face of the elastomeric inner cap.
- For example, the elastomeric inner cap has globally the shape of a cylinder and the rigid outer cap has a globally tubular shape provided with a distal transversal wall. For example, the elastomeric inner cap is received within the rigid outer cap so that the outer wall of the elastomeric inner cap is at least partially in contact with the inner wall of the rigid outer cap, in particular with the inner wall of a tubular part of the rigid outer cap. The elastomeric inner cap may be received with friction within the rigid outer cap.
- Due to its elastomeric nature, the elastomeric inner cap has the capability of being deformed when it is submitted to pressure, for example when a distal pressure is applied. For example, when the elastomeric inner cap has the global shape of a cylinder, it may be deformed radially outwardly under the effect of a longitudinal pressure, for example a distal pressure or a proximal pressure.
- In aspects of the disclosure, the tip cap assembly is provided with stress-limiting means, also referred to as a stress-limiting element, allowing said elastomeric inner cap to be substantially deformed when the assembly closes said passageway, for example when a distal pressure is exerted on the elastomeric inner cap by the syringe tip. In particular, the stress-limiting means allow at least part of the elastomeric inner cap to be deformed radially outwardly, although the elastomeric inner cap is received within the rigid outer cap. The deformation of the elastomeric inner cap ensures an optimal sealing of the fluid passageway and the syringe tip. However, the rigid outer cap could be deformed by the stress transmitted by the elastomeric inner cap over an extended period of storage, and such deformed rigid cap might lead to a deficient sealing. The stress-limiting means avoids the unintended deformation of the rigid outer cap by limiting the amount of stress transmitted to the rigid outer cap by the deformation of the elastomeric inner cap when it closes said passageway, for example when distal pressure is exerted on the elastomeric inner cap, and contributes to maintain the optimal sealing over an extended period of time.
- In aspects of the disclosure, these stress-limiting means include at least one window and more preferably two diametrically opposed longitudinal windows provided onto said rigid outer cap. For example, the window(s) are provided on a tubular wall of the rigid outer cap. These windows accommodate the elastomeric material from the elastomeric inner cap resulting from the deformation caused by both the closing of the passageway and the insertion of the elastomeric cap into the rigid outer cap, for example when the diameter of the elastomeric cap is greater than the internal diameter of the rigid cap. In particular, the windows allow the elastomeric inner cap to be deformed radially outwardly. In particular, when located on a tubular wall of the rigid outer cap, the window(s) may receive some part of the elastomeric inner cap which is deformed radially outwardly.
- In aspects, these stress-limiting means further include a distal opening provided into said rigid outer cap to accommodate the distal deformation of the elastomeric inner cap when the tip cap assembly closes said the fluid passageway, for example when the elastomeric inner cap is submitted to distal pressure. The distal opening may be provided in the distal transversal wall of the rigid outer cap.
- In aspects of the disclosure, the elastomeric cap and the outer rigid cap include holding means, also referred to as a holding element, intended to secure said elastomeric inner cap into said rigid outer cap.
- In aspects of the disclosure, said holding means include a shoulder provided into the rigid outer cap and a radial rim provided onto the elastomeric inner cap, the elastomeric inner cap being proximally blocked by the contact between the distal rim and said shoulder. The shoulder and the radial rim therefore form proximal blocking means, also referred to as a proximal blocking element, for blocking the proximal movement of the elastomeric inner cap with respect to the rigid outer cap.
- In aspects of the disclosure, said holding means further include at least one abutment surface provided into the rigid outer cap, and a distal face provided onto the elastomeric inner cap, said elastomeric inner cap being distally blocked by the contact between the abutment surface and the distal face. The abutment surface and the distal face therefore form distal blocking means, also referred to as a distal blocking element, for blocking the distal movement of the elastomeric inner cap with respect to the rigid outer cap.
- The shoulder, the radial rim, the abutment surface and the distal face form altogether locking means, also referred to as a locking arrangement, both in proximal and in distal translation of the elastomeric inner cap with respect to the rigid outer cap.
- In aspects of the disclosure, the length L1 defined between an abutment surface and the shoulder of the rigid outer cap is greater than the length L2 defined between the distal face and the radial rim of said elastomeric inner cap, L1 and L2 being measured along a longitudinal axis of the tip cap assembly. A gap is therefore left between the rigid outer cap and the elastomeric inner cap: the presence of such a gap simplifies the assembling of the tip cap assembly and allows an optimal and sustainable closure, even with non-standard syringes.
- A second aspect of the disclosure is an injection system including a longitudinal barrel, a distally projecting tip provided with a fluid passageway extending therethrough, a distal surface and a lateral surface, where the injection system further includes a tip cap assembly according to the first aspect of the disclosure.
- A third aspect of the disclosure is an injection system including a longitudinal barrel having a distally projecting tip and a tip cap assembly, said distally projecting tip being provided with a fluid passageway extending therethrough, a distal surface and a lateral surface, said tip cap assembly including an elastomeric inner cap including a frustoconical protrusion and a rigid outer cap which can be securely disposed around said elastomeric inner cap, said assembly being configured so that, when said tip cap assembly closes said passageway, said frustoconical protrusion contacts said distally projecting tip only at the distal surface.
- In aspects of the disclosure, the rigid outer cap is provided with a sterility skirt intended for a circumferential sealing of the lateral surface of said distally projecting tip when said assembly closes said fluid passageway. This sterility skirt maintains sterile the distal tip of the syringe during storage and thus the content of the injection system.
- In aspects of the disclosure, the sterility skirt is further provided with at least one annular ridge. For example, the annular ridge is provided on the inner wall of the sterility skirt. The at least one annular ridge may enhance the sealing provided between the sterility skirt and the lateral surface of the distally projecting tip.
- In aspects of the disclosure, the injection system is provided with a collar securely engaged around said distal tip, having an inner thread and a distal rim, and wherein said rigid outer cap is provided with an outer thread able to cooperate with the thread of the collar to close said passageway.
- In aspects of the disclosure, the rigid outer cap is provided with a proximal abutment surface contacting the distal rim of the collar when said tip cap assembly closes said passageway.
- A fourth aspect of the disclosure is a tip cap assembly adapted to close the fluid passageway of the distally projecting tip of an injection system. The tip cap assembly includes an elastomeric inner cap having a distal portion and a proximal portion and a rigid outer cap adapted to be securely disposed around the elastomeric inner cap. The proximal portion of the elastomeric inner cap includes a frustoconical protrusion and a proximal face having a diameter greater than the diameter of the fluid passageway of the injection system.
- In aspects of the disclosure, the tip cap assembly further includes a stress-limiting means to accommodate deformation of the elastomeric inner cap when the assembly closes the fluid passageway. The stress-limiting means may include at least one window in the rigid outer cap and, preferably, two diametrically opposed longitudinal windows. Alternatively or in addition, the stress-limiting means may include a distal opening in the rigid outer cap.
- In aspects of the disclosure, the elastomeric cap and the outer rigid cap each include at least one engagement surface, wherein contact of the engagement surface of the elastomeric inner cap with the engagement surface of the rigid outer cap secures the elastomeric inner cap to the rigid outer cap. The engagement surface of the rigid outer cap may include a shoulder, and the engagement surface of the elastomeric inner cap may include a radial rim, wherein the radial rim contacts the shoulder at least when a proximal pressure is applied to the elastomeric inner cap. Alternatively or in addition, the engagement surface of the rigid outer cap may include at least one abutment surface, and the engagement surface of the elastomeric inner cap may include a distal face, wherein the at least one abutment surface contacts the distal face at least when a distal pressure is applied to the elastomeric inner cap. In the aspect where the rigid outer cap includes a first engagement surface including a shoulder and a second engagement surface including an abutment surface and the elastomeric inner cap includes a first engagement surface including a radial rim and a second engagement surface including distal face, the length L1 defined between the abutment surface and the shoulder of the rigid outer cap may be greater than the length L2 defined between the distal face and the radial rim of the elastomeric inner cap.
- In aspects of the disclosure, the outer rigid cap may include a distal portion, a central portion, and a proximal portion. The at least one stress-limiting means, preferably a longitudinal window, may be located in the distal portion of the outer rigid cap and the proximal section may have a frustoconical shape. The outer rigid cap may further include internal and/or external reinforcement means, also referred to as reinforcement elements. The reinforcement means may be longitudinal or circumferential ribs.
- In aspects of the disclosure, the elastomeric inner cap may include a distal portion and a proximal portion. The distal portion may be essentially cylindrical with a flat distal face and the proximal portion may comprise a frustoconical protrusion. The diameter of the proximal portion may be less than the diameter of the distal portion. The proximal portion of the elastomeric inner cap may also include a circular bump.
- In aspects of the disclosure, the elastomeric cap may adopt three different configurations: a free configuration when it is not assembled with the rigid cap, a first stressed configuration when it is assembled into the rigid cap to form the tip cap assembly and a second stressed configuration due to the distal pressure applied by the distally projecting tip when the tip cap assembly closes the fluid passageway of an injection system.
- In the second stressed configuration, the distal end of the elastomeric inner cap is received in the distal portion of the outer rigid cap and the proximal portion of the elastomeric inner cap is received in the central portion of the outer rigid cap. The outside diameter of the distal portion of the elastomeric inner cap may be greater than the inside diameter of the distal portion of the outer rigid cap and/or the outside diameter of the proximal portion of the elastomeric inner cap may be greater than the inside diameter of the central portion of the outer rigid cap in order to enhance contact between the engagement surfaces of the outer rigid cap and the elastomeric inner cap.
- In the third stressed configuration, the elastomeric inner cap is further compressed between the rigid inner cap and the distally projecting tip of the injection system.
- In both the second and the third stressed conditions, the stress-limiting means acts to reduce the stress placed on the rigid outer cap due to the compression of the elastomeric inner cap.
- A fifth aspect of the disclosure is an injection system including a longitudinal barrel, and a distally projecting tip having a fluid passageway extending therethrough, a distal surface, and a lateral surface, wherein the injection system further includes a tip cap assembly as described above.
- In aspects of the disclosure, when the tip cap assembly closes the fluid passageway, the frustoconical protrusion only contacts the distal surface of the distally projecting tip.
- In aspects of the disclosure, the rigid outer cap may further include a sterility skirt that provides a circumferential seal between the lateral surface of the distally projecting tip and the rigid outer cap when the tip cap assembly closes the passageway. The sterility skirt may include at least one annular ridge.
- In aspects of the disclosure, the injection system may further include a collar securely engaged around the distal tip. The collar may have an inner thread and a distal rim. In this aspect, the rigid outer cap includes an outer thread adapted to cooperate with the inner thread of the collar in order to close the passageway. The rigid outer cap may further include a proximal abutment surface that contacts the distal rim of the collar when the tip cap assembly closes the passageway. This engagement of the proximal abutment surface and the distal rim of the collar prevents rotational movement of the tip with respect to the injection system to avoid damage to the tip cap assembly and assures correct positioning of the tip cap with regard to the collar to signal the user that a seal has been formed.
- A sixth aspect of the disclosure is an injection system including a longitudinal barrel, a distally projecting tip and a collar provided with an inner thread. The collar is securely engaged around the distally projecting tip and the distally projecting tip has a lateral surface and a fluid passageway extending therethrough. The injection system further includes a tip-cap assembly including an elastomeric inner cap and a rigid outer cap that is or can be securely disposed around the elastomeric inner cap. The rigid outer cap of the tip cap assembly includes an outer thread intended to be screwed with the inner thread of the collar, a frustoconical extension and a radial recess between the outer thread and the frustoconical extension. The frustoconical extension is intended to ensure a circumferential sealing of the distally projecting tip around the lateral surface in order to act as a sterility skirt when the tip-cap assembly closes the passageway of the projecting tip.
- In aspects of the disclosure, the frustoconical extension of the rigid outer cap may be provided with at least one annular ridge, preferably three.
- A seventh aspect of the disclosure is a tip-cap assembly adapted to close the fluid passageway of the distally projecting tip of an injection system. The tip-cap assembly includes an elastomeric inner cap which has a distal face and a radial rim, and a length L2 defined as the distance between the distal face and the radial rim. The tip-cap assembly further includes a rigid outer cap which is or can be securely disposed around the elastomeric inner cap, with a shoulder and at least one abutment surface, and a length L1 defined as the distance between the at least one abutment surface and the shoulder. The elastomeric inner cap is distally blocked by the contact between the distal face and the at least one abutment surface, and proximally blocked by the contact between the radial rim and the shoulder. The length L1 is greater than the length L2 in order to allow a limited translation of the elastomeric inner cap within the rigid outer cap.
- The present invention will now be described in greater detail based on the following description and the appended drawings, in which:
-
FIG. 1A is a side view of a syringe without a tip cap; -
FIG. 1B is a perspective view of a syringe without a tip cap; -
FIG. 1C is a cross-section view of a syringe without a tip cap; -
FIG. 2A is a side view of the syringe ofFIGS. 1A-1C closed by a tip cap assembly of an abstract of the present disclosure; -
FIG. 2B is a perspective view of the syringe ofFIGS. 1A-1C closed by a tip cap assembly of an aspect of the present disclosure; -
FIG. 2C is a cross-section view of the syringe ofFIGS. 1A-1C closed by a tip cap assembly of an aspect of the present disclosure; -
FIG. 3A is a side view of the rigid outer cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 3B is a cross-section view of the rigid outer cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 3C is another cross-section view of the rigid outer cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 3D is a perspective view of the rigid outer cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 3E is a cross-section perspective view of the rigid outer cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 4A is a side view of the elastomeric inner cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 4B is a perspective view of the elastomeric inner cap of the tip cap assembly ofFIGS. 2A and 2B ; -
FIG. 5 is the theoretical superimposition of the rigid outer cap ofFIGS. 3A, 3B and 3C on the elastomeric inner cap ofFIGS. 4A and 4B ; -
FIG. 6A is a cross-section view of a tip cap assembly according to an aspect of the present disclosure. -
FIG. 6B is a cross-section view of a tip cap assembly according to another aspect of the present disclosure; -
FIG. 7 is a cross-section view of a tip cap assembly mounted on the syringe ofFIGS. 1A, 1B and 1C ; -
FIG. 8 is a perspective view of the syringe ofFIGS. 1A-1C closed by a tip cap assembly according to an aspect of the present disclosure; and -
FIG. 9 is a perspective view of the syringes ofFIGS. 1A-1C closed by a tip cap assembly according to another aspect of the present disclosure. - For purposes of the description hereinafter, the terms “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the invention as it is oriented in the drawing figures.
-
FIGS. 1A-1C show aninjection system 10 in the form of a luer syringe according to an aspect of the disclosure. The present disclosure could be used with any other types of injection systems, such as a pen, or an infusion system, provided they include a distally projecting tip. For sake of clarity, the present disclosure will only be described with aluer syringe 10. Thesyringe 10 includes alongitudinal barrel 11 having a longitudinal axis A, aproximal flange 12 and adistally projecting tip 13. Thedistally projecting tip 13 includes afluid passageway 14 extending therethrough, a distal surface 15 and a lateral surface 16 (seeFIG. 1C ) which is substantially tubular. Acollar 20 is securely engaged around thetip 13, for example by clipping, screwing or welding. In another aspect (not shown), thecollar 20 is molded with the longitudinal barrel with which it forms only one part. Thecollar 20 is provided with aninner thread 21 and adistal rim 22. Thesyringe 10 is further provided with a stopper and a plunger rod, not shown inFIGS. 1A-1C . - As shown in
FIGS. 2A-2C , thesyringe 10 may be sealingly closed by atip cap assembly 30. Thistip cap assembly 30 includes a rigidouter cap 40 which receives an elastomericinner cap 50. - The rigid
outer cap 40 will now be described with references toFIGS. 3A-3E . - The rigid
outer cap 40 includes an essentiallytubular wall 41 having a longitudinal axis A′ and defining acavity 41 a open on both distal and proximal ends. Thetubular wall 41 includes three different portions: adistal portion 42, acentral portion 43 and aproximal portion 44. - The
distal portion 42 has an essentially tubular shape and includes a distal opening 42 a and twolongitudinal windows 42 b (seeFIG. 3E , only one visible inFIGS. 3A and 3B ), diametrically opposed, in the example shown. Eachwindow 42 b is enclosed on its outside by twolongitudinal ribs 42 c and one distalradial rib 42 d and on its inside by two abutment surfaces 42 e and ashoulder 42 f. In other aspect (not shown), one, three or four abutment surfaces 42 e are provided into therigid cap 40. A length L1, measured along axis A′, is defined between the abutment surfaces 42 e and theshoulder 42 f and consists in the longitudinal dimension of thelongitudinal windows 42 b. Theshoulder 42 f is located between thedistal portion 42 and thecentral portion 43. In other aspects (not shown), thedistal portion 42 includes one, three or fourwindows 42 b. - The
central portion 43 has an essentially tubular shape and includes on the inside a plurality oflongitudinal rims 43 a linked with a shoulder 43 b. On the outside, aring 43 c including aproximal abutment surface 43 d is linked with two longitudinal ribs 43 e and thelongitudinal ribs 42 c. The longitudinal ribs 43 e only extend along part of thecentral portion 43 while thelongitudinal ribs 42 c, enclosing thewindows 42 b, extend along both thedistal portion 42 and part of thecentral portion 43. The shoulder 43 b is located between thecentral portion 43 and theproximal portion 44. - The
proximal portion 44 has an extension having the shape of a truncated cone or frustoconical extension 44 a. The frustoconical extension 44 a includes aproximal opening 44 b and three annular ridges 44 c. On the outside, anouter thread 44 d extends from thering 43 c of thecentral portion 43 and is separated from the frustoconical extension 44 a by a radial recess 44 e. In another aspect (not shown), therigid cap 40 is not provided with anouter thread 44 d and theproximal portion 44 only includes a frustoconical extension 44 a with ridges 44 c. This aspect can then be used with asyringe 10 that is not provided with acollar 20. - The rigid outer cap can be made of a rigid polymer such as polypropylene, polyethylene, polyvinylchloride, polystyrene, polycarbonate or a copolymer such as acrylonitrile butadiene styrene or styrene acrylonitrile.
- The elastomeric
inner cap 50 will now be described with reference toFIGS. 4A and 4B . It includes adistal portion 51 and aproximal portion 52 both having a longitudinal axis A″. Thedistal portion 51 has an essentially cylindrical shape and a flatdistal face 53. Theproximal portion 52 includes afrustoconical protrusion 54 having the shape of a truncated cone, aproximal face 55 essentially perpendicular to the axis A″ and acircular bump 56. Theproximal portion 52 has a smaller average diameter than thedistal portion 51 and aradial rim 57 is located at the connection between theproximal portion 52 and thedistal portion 51. Preferably the cone angle a of the truncated cone forming thefrustoconical protrusion 54 ranges from 40° to 60° relative to axis A″, more preferably is 50° relative to axis A″. The length L2 of thedistal portion 51, measured along axis A″, is defined between theradial rim 57 and the flatdistal face 53. In the aspect ofFIGS. 4A and 4B , theproximal face 55 is essentially flat. In other aspects (not shown), theproximal face 55 has a curvature radius, the center of which being situated on the axis A″. The diameter of theproximal face 55 is preferably greater than the diameter of thefluid passageway 14 of thedistal tip 13. As appears fromFIGS. 4A and 4B , theproximal face 55 is the most proximal face of the elastomericinner cap 50. - The
elastomeric cap 50 is able to adopt three different configurations: a free configuration when it is not assembled with therigid cap 40, a first stressed configuration when it is assembled into therigid cap 40 to form thetip cap assembly 30 and a second stressed configuration due to the distal pressure applied by thedistally projecting tip 13 when thetip cap assembly 30 closes thefluid passageway 14 of aninjection system 10, as will be explained later. - Suitable materials for the
elastomeric cap 50 of the invention include natural rubber, acrylate-butadiene rubber, cis-polybutadiene, chloro or bromobutyl rubber, chlorinated polyethylene elastomers, polyalkylene oxide polymers, ethylene vinyl acetate, fluorosilicone rubbers, hexafluoropropylene-vinylidene fluoride-tetrafluoroethylene terpolymers, butyl rubbers, polyisobutene, synthetic polyisoprene rubber, silicone rubbers, styrene-butadiene rubbers, tetrafluoroethylene propylene copolymers, thermoplastic-copolyesters, thermo-plastic elastomers, or the like or a combination thereof. - The superposition of cross-sectional views of the elastomeric inner cap 50 (
FIGS. 4A-4B ) and the rigid outer cap 40 (FIGS. 3A-3E ) is shown as a theoretical view inFIG. 5 , as the represented shape of the elastomericinner cap 50 on this Figure is that of its free configuration and therefore overlaps (at circular bump 56) the shape of the rigidouter cap 40. Thedistal portion 51 of the elastomericinner cap 50 is intended to be received in thedistal portion 42 of therigid cap 40, and theproximal portion 52 of the elastomericinner cap 50 is intended to be received in thecentral portion 43 of therigid cap 40. In the theoretical view ofFIG. 5 , the axis A′ of therigid cap 40 is superposed with the axis A″ of the elastomericinner cap 50 and the length L1 included between the abutment surface 42 e and theshoulder 42 f is slightly greater than the length L2 of thedistal portion 51 of the elastomericinner cap 50. In another aspect (shown inFIG. 7 ), the length L1 is equal to the length L2 of thedistal portion 51. In a last aspect (not shown), the length L1 is slightly smaller in comparison to the length L2. Finally, thecircular bump 56 of the elastomericinner cap 50 has a diameter slightly greater than the internal diameter of thecentral portion 43 of therigid cap 40. - A
tip cap assembly 30 ready to be used, with the elastomericinner cap 50 assembled into therigid cap 40, is shown inFIGS. 6A and 6B . The elastomericinner cap 50 is maintained inside therigid cap 40 and is in its first stressed configuration: itsdistal portion 51 is enclosed between the abutment surface 42 e and theshoulder 42 f of therigid cap 40 and its longitudinal axis A″ is superposed with the longitudinal axis A′ of therigid cap 40. The elastomericinner cap 50 is distally blocked by the contact between itsdistal face 53 and the abutment surfaces 42 e of therigid cap 40, and proximally blocked by the contact between itsradial rim 57 and theshoulder 42 f of therigid cap 40. In the embodiment ofFIGS. 6A and 6B , the length L1 is greater than the length L2 and a gap G exists between therigid cap 40 and theelastomeric cap 50 which allows a limited translation of theelastomeric cap 50 within therigid cap 40. In the embodiments where L1 is equal to or smaller than L2, the abutment surfaces 42 e of therigid cap 40 contact directly thedistal face 53 of the elastomericinner cap 50 while theshoulder 42 f of therigid cap 40 contacts theradial rim 57 of theelastomeric cap 50. Consequently, theradial rim 57 contacts theshoulder 42 f at least when a proximal pressure is applied on the elastomericinner cap 50, while the abutment surfaces 42 e contact thedistal face 53 at least when a distal pressure is applied on the elastomericinner cap 50. The abutment surfaces 42 e and theshoulder 42 f of therigid cap 40, together with thedistal face 53 and theradial rim 57 therefore form holding means to secure the elastomericinner cap 50 within therigid cap 40. - Furthermore, the average diameter of the
distal portion 51 of the elastomericinner cap 50 is chosen to be slightly larger than the inside diameter of thedistal portion 42 of therigid cap 40. As a result, the elastomericinner cap 50 is tightened on its diameter, is slightly deformed, and part of this elastomericinner cap 50 even protrudes further through thewindows 42 b of therigid cap 40 when assembled (as shown inFIG. 7 ). This deformation thus enhances the contact area between the abutments surfaces 42 e and thedistal face 53 of the elastomericinner cap 50. Similarly, and as shown inFIG. 5 , thecircular bump 56 of theproximal portion 52 has a diameter slightly larger than the inside diameter of thecentral portion 43 of therigid cap 40. Consequently, theproximal portion 52 is tightened on its whole diameter, and thefrustoconical protrusion 54 is deformed over its length, thus further extending toward theproximal portion 44 of therigid cap 40. These deformations further contribute to maintain the elastomericinner cap 50 in therigid cap 40. In the aspect where L1 is smaller than L2 (not shown), thedistal portion 51 of theelastomeric cap 50 is tightened on its length and slightly deformed. - Due to the specific shape of the
rigid cap 40 and the elastomericinner cap 50, the assembly of thetip cap 30 can be obtained by aligning the axis A′ of therigid cap 40 with the axis A″ of the elastomericinner cap 50, theproximal portion 52 of the elastomericinner cap 50 facing the distal opening 42 a of therigid cap 40. A proximal pressure applied on the elastomericinner cap 50, or a distal pressure applied on therigid cap 40 allows the introduction and the slight deformation of the elastomericinner cap 50 into therigid cap 40. This operation can be facilitated by lubrication of the elastomericinner cap 50, lubrication of thecavity 41 a of therigid cap 40, or both. In the aspect where L1 is greater than L2, the gap G leads to a simpler assembling by allowing a greater deformation of theelastomeric cap 50 and permitting to have higher ranges of manufacturing tolerances. Thetip cap assembly 30 of the present aspect is therefore very fast to assemble and the probability of an incorrect assembling is very limited. - The
tip cap assembly 30 is now ready to be connected with asyringe 10 as shown inFIG. 7 . The axis A′, A″ of the tip cap assembly are aligned with the axis A of thesyringe 10, theproximal opening 44 b of thetip cap assembly 30 facing thedistally projecting tip 13 of thesyringe 10. When thetip cap assembly 30 is provided with anouter thread 44 d, a rotational movement is required to screw theouter thread 44 d into theinner thread 21 of thecollar 20 of thesyringe 10. Before the end of the rotation, the projectingtip 13 comes in contact with theproximal face 55 of the elastomericinner cap 50. In the aspect where L1 is greater than L2, theelastomeric cap 50 is pushed against the abutment surfaces 42 e of therigid cap 40 and then progressively compressed. In the aspects where L1 is equal or smaller than L2, theelastomeric cap 50 is already immobilized inside therigid cap 40 and is directly compressed by the projectingtip 13. Thereafter, thelateral surface 16 of the projectingtip 13 comes in contact with the frustoconical extension 44 a, which is progressively deformed radially outwardly. At the end of the rotation, theproximal abutment surface 43 d of thetip cap assembly 30 comes in contact with thedistal rim 22 of thecollar 20. Thus, thetip cap assembly 30 is secured to thecollar 20 and to thedistally projecting tip 13 as shown inFIGS. 2A, 2B and 7 . Theproximal abutment surface 43 d of therigid cap 40 cooperates with thedistal rim 22 of thecollar 20 to prevent any further rotational movement that would damage thetip cap assembly 30. This cooperation also ensures the correct positioning of thetip cap 30 with respect to thecollar 20 and provides the user with a tactile indication that thesyringe 10 is hermetically sealed. In another aspect (not shown), theproximal abutment surface 43 d is not present on thering 43 c but integrated on the outer surface of therigid cap 40. - In an aspect where the
syringe 10 is not provided with acollar 20 and thetip cap assembly 30 is consequently not provided with anouter thread 44 d or aring 43 c (not shown), thetip cap assembly 30 is simply mounted on thedistally projecting tip 13 by a proximal movement. - As shown in
FIG. 7 , the elastomericinner cap 50 does not substantially penetrate thefluid passageway 14 since the diameter of theproximal face 55 is at least greater than the diameter of thefluid passageway 14. When thetip cap assembly 30 is plugged on the tip, the elastomericinner cap 50 is compressed between the distally projectingtip 13 and the abutment surfaces 42 e of therigid cap 40, which significantly deforms theproximal portion 52 of the elastomericinner cap 50 in order to ensure the tight sealing of thefluid passageway 14. Part of this deformation is absorbed by the specific shape of thefrustoconical protrusion 54 of theelastomeric cap 50, which contributes to limit both axial and radial stress transmitted to therigid cap 40. The deformation of theelastomeric cap 50 is also partially allowed by the distal opening 42 a and thelongitudinal windows 42 b of therigid cap 40, as shown inFIG. 7 , further reducing the amount of axial stress transmitted to therigid cap 40 through the abutment surfaces 42 e. Thefrustoconical protrusion 54 of the elastomericinner cap 50 as well as the distal opening 42 a and thelongitudinal windows 42 b of therigid cap 40 therefore constitute stress-limiting means that allow theelastomeric cap 50 to be substantially deformed when thetip cap assembly 30 closes thepassageway 14 of thesyringe 10. Unintended deformation of therigid cap 40 and in particular of itsdistal portion 42, due to the stress resulting of the compression of theelastomeric cap 50 over time, is therefore avoided: the syringe can be kept perfectly sealed during storage time. Thanks to the appropriate connection of the tip cap assembly with the projectingtip 13, neither the nature nor the quality, for example the purity, of the fluid stored inside the syringe is altered, even after an extended period of storage. Wastage of valuable fluids is therefore avoided, as well as unacceptable risks for patients and medical staff that would be in contact with the fluid. The specific geometry of therigid cap 40, and in particular the distal opening 42 a, thewindows 42 b, the abutment surfaces 42 e, as well as the specific geometry of the elastomericinner cap 50 and in particular, thefrustoconical protrusion 54, therefore allow a hermetical and sustainable sealing of the projectingtip 13 of thesyringe 10. - The
rigid cap 40 is reinforced on its outside by the longitudinal ribs 43 e, thelongitudinal ribs 42 c and the distalradial ribs 42 d and on its inside by thelongitudinal rims 43 a and the shoulder 43 b, in order to resist against any deformation that might result from the stress transmitted by the elastomericinner cap 50 when thetip cap assembly 30 closes thefluid passageway 14, or by the user while manipulating the tip cap assembly. Longitudinal ribs 43 e, thelongitudinal ribs 42 c, the distalradial ribs 42 d, thelongitudinal rims 43 a and the shoulder 43 b therefore constitute reinforcement means. - In the aspect where L1 is greater than L2, the gap G between the
rigid cap 40 and theelastomeric cap 50 is also useful to be compatible with different kinds of syringes showing unconventional lengths of distally projectingtip 13, for example syringes that have not been designed according to usual standards. As a result, thetip cap assembly 30 according to this specific aspect can provide an optimal and sustainable sealing even in the case of non-standard syringes. - In the closed position shown in
FIG. 7 , the radial recess 44 e allows a limited radial deformation of the frustoconical extension 44 a due to the contact with thelateral surface 16 of thedistally projecting tip 13. As a result, the frustoconical extension 44 a extends around and hermetically seals thedistally projecting tip 13, the three annular ridges 44 c being in tight contact with itslateral surface 16. This ensures the circumferential sealing of thelateral wall 16 of thedistal tip 13 and allows the sterile maintenance of thecavity 41 a of thetip cap assembly 30 and therefore the projectingtip 13 of thesyringe 10. In addition, the circumferential sealing of thelateral wall 16 of thedistal tip 13 is performed even when thedistal tip 13 is not perfectly circular. Adistal tip 13 showing a limited asymmetry or a ellipsoidal section resulting of manufacturing tolerances does not deteriorate the sterility of thecavity 41 a of thetip cap assembly 30. The frustoconical extension 44 a therefore acts as a sterility skirt during the storage time of a prefilled syringe and significantly limits or eliminates migration of contaminants from the projecting tip to the fluid before and during the step of injection to a patient. In other aspects (not shown), the sterility skirt 44 a is provided with at least one annular ridge 44 c. - At the end of the storage time, immediately before injecting the fluid stored to a patient, a limited effort is required to unscrew the
tip cap assembly 30 from thecollar 20 and thus to open thefluid passageway 14 of thesyringe 10. Indeed, the specific shape of thefrustoconical protrusion 54 of thetip cap assembly 30 limits the area of contact between theelastomeric cap 50 and thedistally extending tip 13 to the distal surface 15, therefore avoiding any contact between the elastomericinner cap 50 and thelateral surface 16 or thefluid passageway 14 of thedistally extending tip 13. This significantly reduces or cancels the sticking phenomenon that may happen after an extended storage period and therefore allows a quick and easy removal of thetip cap assembly 30. Thefluid passageway 14 is also maintained clean of particles since thefrustoconical protrusion 54 does not contact directly the inside surface of thefluid passageway 14. During the opening of asyringe 10, thefrustoconical protrusion 54 of the elastomericinner cap 50 also creates a spring effect to thetip cap assembly 30 which further contributes to an easy removal. Finally, reinforcement means 43 e, 42 c, 42 d, 43 a and 43 b allow for a thinnertubular wall 41 of therigid cap 40. The deformation of therigid cap 40 during the removal step is therefore limited, which again ensures an easy removal. The tip cap assembly according to the present disclosure therefore can reduce economic loss by preventing discarding prefilled syringes before use. Furthermore, injection can be done at very short notice and without excessive effort. This could save patients requiring immediate treatment. - In another aspect shown in
FIG. 8 , thetip cap assembly 100 has the global shape of an elliptic cylinder and includes 141 and 142 on the outer surface of theelliptical reinforcement ridges rigid cap 140, the proximal portion (not visible) of therigid cap 140 being substantially cylindrical to fit within thesyringe collar 20 and all other features being similar to those previously described for thetip cap assembly 30 ofFIGS. 1-7 . Comparing to the circular cylindertip cap assembly 30, thetip cap assembly 100 is easier to screw or remove from thesyringe collar 20 as the elliptical shape provides more contact surface to the user's fingers, leading to a better gripping ability. - In another aspect shown in
FIG. 9 , thetip cap assembly 200 has globally the shape of an elliptical cylinder and the outer surface of therigid cap 240 is provided withlongitudinal reinforcement ridges 241 surrounding the windows 242 (only one visible inFIG. 9 ), and twoflat surfaces 243 placed between the windows 242. The proximal portion (not visible) of therigid cap 240 is substantially cylindrical to fit within thesyringe collar 20 and all other features are similar to those previously described for thetip cap assembly 30 ofFIGS. 1-7 . Comparing to the circular cylindertip cap assembly 30, thetip cap assembly 200 is easier to screw or remove from thesyringe collar 20 as the elliptical shape provides more contact surface to the user's fingers, leading to a better gripping ability. - In other aspects (not shown), the
tip cap assembly 30 can be provided with a tamper evidence feature, for example in the form of breakable tabs between thecollar 20 and thering 43 c of therigid cap 40. In other aspects (not shown), the tamper evidence features also include a security ring provided on thecollar 20. - Thanks to its unique structure, the tip cap assemblies according to the present disclosure allows maintaining a perfect sealing overtime, protecting the syringe tip from contamination during storage time and providing an opening with limited effort.
Claims (20)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17/240,484 US20210244892A1 (en) | 2013-10-15 | 2021-04-26 | Tip Cap Assembly for Closing an Injection System |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20130306414 EP2862587A1 (en) | 2013-10-15 | 2013-10-15 | Tip cap assembly for closing an injection system |
| EP13306414.7 | 2013-10-15 | ||
| PCT/EP2014/071950 WO2015055608A1 (en) | 2013-10-15 | 2014-10-14 | Tip cap assembly for closing an injection system |
| US201615028950A | 2016-04-13 | 2016-04-13 | |
| US17/240,484 US20210244892A1 (en) | 2013-10-15 | 2021-04-26 | Tip Cap Assembly for Closing an Injection System |
Related Parent Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/028,950 Continuation US11013865B2 (en) | 2013-10-15 | 2014-10-14 | Tip cap assembly for closing an injection system |
| PCT/EP2014/071950 Continuation WO2015055608A1 (en) | 2013-10-15 | 2014-10-14 | Tip cap assembly for closing an injection system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20210244892A1 true US20210244892A1 (en) | 2021-08-12 |
Family
ID=49517455
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/028,950 Active 2036-01-05 US11013865B2 (en) | 2013-10-15 | 2014-10-14 | Tip cap assembly for closing an injection system |
| US17/240,484 Pending US20210244892A1 (en) | 2013-10-15 | 2021-04-26 | Tip Cap Assembly for Closing an Injection System |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/028,950 Active 2036-01-05 US11013865B2 (en) | 2013-10-15 | 2014-10-14 | Tip cap assembly for closing an injection system |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11013865B2 (en) |
| EP (5) | EP2862587A1 (en) |
| JP (1) | JP6700177B2 (en) |
| KR (4) | KR102591387B1 (en) |
| CN (5) | CN113101461B (en) |
| ES (3) | ES2972500T3 (en) |
| RU (1) | RU2645240C2 (en) |
| WO (1) | WO2015055608A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478449B1 (en) | 2019-11-25 | 2025-11-25 | International Medical Industries Inc | Needle packaging and disposal assembly |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9259535B2 (en) | 2006-06-22 | 2016-02-16 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
| US8167847B2 (en) | 2006-06-22 | 2012-05-01 | Excelsior Medical Corporation | Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly |
| US11229746B2 (en) | 2006-06-22 | 2022-01-25 | Excelsior Medical Corporation | Antiseptic cap |
| US9700710B2 (en) | 2006-06-22 | 2017-07-11 | Excelsior Medical Corporation | Antiseptic cap equipped syringe |
| US9078992B2 (en) | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
| US10016587B2 (en) | 2011-05-20 | 2018-07-10 | Excelsior Medical Corporation | Caps for needleless connectors |
| US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
| US9867975B2 (en) | 2011-05-23 | 2018-01-16 | Excelsior Medical Corporation | Antiseptic line cap |
| EP2731658B1 (en) | 2011-07-12 | 2020-04-01 | Pursuit Vascular, Inc. | Device for delivery of antimicrobial agent into trans-dermal catheter |
| US10391262B2 (en) * | 2014-03-18 | 2019-08-27 | Windgap Medical, Inc. | Removable actuating cap for use with an auto-injector assembly |
| EP2862587A1 (en) | 2013-10-15 | 2015-04-22 | Becton Dickinson France | Tip cap assembly for closing an injection system |
| WO2015168677A1 (en) | 2014-05-02 | 2015-11-05 | Excelsior Medical Corporation | Strip package for antiseptic cap |
| JP6822978B2 (en) | 2015-05-08 | 2021-01-27 | アイシーユー・メディカル・インコーポレーテッド | Medical connector configured to accept the emitter of a therapeutic agent |
| EP3511041B1 (en) | 2015-06-12 | 2023-06-07 | Becton Dickinson France | Adaptor for a drug delivery device and drug delivery device |
| US10039913B2 (en) | 2015-07-30 | 2018-08-07 | Carefusion 303, Inc. | Tamper-resistant cap |
| EP3269418A1 (en) * | 2016-07-12 | 2018-01-17 | Becton Dickinson France | Tip cap assembly, medical injection system and process for producing a medical injection system |
| WO2018065312A1 (en) * | 2016-10-04 | 2018-04-12 | Gerresheimer Regensburg Gmbh | Method for producing a syringe with an integrated closure element |
| AU2017341782B2 (en) | 2016-10-14 | 2023-03-16 | Icu Medical, Inc. | Sanitizing caps for medical connectors |
| US10918754B2 (en) | 2017-03-27 | 2021-02-16 | Regeneron Pharmaceuticals, Inc. | Sterilisation method |
| US11350918B2 (en) * | 2017-04-19 | 2022-06-07 | Baxter International Inc. | Non-clogging dispensing device |
| WO2018204206A2 (en) | 2017-05-01 | 2018-11-08 | Icu Medical, Inc. | Medical fluid connectors and methods for providing additives in medical fluid lines |
| CA3077062A1 (en) * | 2017-10-06 | 2019-04-11 | Nordson Corporation | Tamper-evident closure assembly |
| WO2019118588A1 (en) | 2017-12-13 | 2019-06-20 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| WO2019123489A1 (en) * | 2017-12-19 | 2019-06-27 | Matex Lab S.P.A. | Cartridge for a syringe, and corresponding syringe |
| WO2019123488A1 (en) * | 2017-12-19 | 2019-06-27 | Matex Lab S.P.A. | Cartridge for a syringe, and corresponding syringe |
| US11541180B1 (en) | 2017-12-21 | 2023-01-03 | Patrick Vitello | Closure assembly having a snap-fit construction |
| US20190231985A1 (en) * | 2018-01-26 | 2019-08-01 | Becton, Dickinson And Company | Flush Syringe With Shielded Tip |
| EP3520846B1 (en) * | 2018-01-31 | 2025-11-19 | Becton Dickinson France | Protection device for a needle |
| US11278681B1 (en) | 2018-02-20 | 2022-03-22 | Robert Banik | Tamper evident adaptor closure |
| US11413406B1 (en) | 2018-03-05 | 2022-08-16 | Jonathan J. Vitello | Tamper evident assembly |
| EP3569272B1 (en) * | 2018-05-14 | 2025-07-23 | SCHOTT Pharma Schweiz AG | Closure for a container for pharmaceutical preparations and container that has been closed |
| JP2021525595A (en) * | 2018-06-01 | 2021-09-27 | プレサージュ バイオサイエンシズ,インコーポレイテッド | Thin multidrug injection system and method |
| US11857751B1 (en) * | 2018-07-02 | 2024-01-02 | International Medical Industries Inc. | Assembly for a medical connector |
| US11779520B1 (en) | 2018-07-02 | 2023-10-10 | Patrick Vitello | Closure for a medical dispenser including a one-piece tip cap |
| US11793987B1 (en) | 2018-07-02 | 2023-10-24 | Patrick Vitello | Flex tec closure assembly for a medical dispenser |
| US11690994B1 (en) | 2018-07-13 | 2023-07-04 | Robert Banik | Modular medical connector |
| US11426328B1 (en) | 2018-08-31 | 2022-08-30 | Alexander Ollmann | Closure for a medical container |
| EP3632489B1 (en) * | 2018-10-05 | 2023-08-23 | Becton Dickinson France | Cap remover having gasket compression |
| USD948713S1 (en) | 2019-09-03 | 2022-04-12 | International Medical Industries, Inc. | Asymmetrical self righting tip cap |
| US11471610B1 (en) | 2018-10-18 | 2022-10-18 | Robert Banik | Asymmetrical closure for a medical device |
| US11541220B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Needleless connector with antimicrobial properties |
| US11400195B2 (en) | 2018-11-07 | 2022-08-02 | Icu Medical, Inc. | Peritoneal dialysis transfer set with antimicrobial properties |
| US11534595B2 (en) | 2018-11-07 | 2022-12-27 | Icu Medical, Inc. | Device for delivering an antimicrobial composition into an infusion device |
| US11541221B2 (en) | 2018-11-07 | 2023-01-03 | Icu Medical, Inc. | Tubing set with antimicrobial properties |
| US11517732B2 (en) | 2018-11-07 | 2022-12-06 | Icu Medical, Inc. | Syringe with antimicrobial properties |
| JP2022513096A (en) | 2018-11-21 | 2022-02-07 | アイシーユー・メディカル・インコーポレーテッド | Antibacterial device with cap with ring and insert |
| CN118718181A (en) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | Device and method for precise dose delivery |
| EP3760254A1 (en) * | 2019-07-01 | 2021-01-06 | Becton Dickinson France | Tip cap for a medical injection device |
| US11911339B1 (en) | 2019-08-15 | 2024-02-27 | Peter Lehel | Universal additive port cap |
| US11697527B1 (en) | 2019-09-11 | 2023-07-11 | Logan Hendren | Tamper evident closure assembly |
| USD944977S1 (en) * | 2020-02-03 | 2022-03-01 | Becton Dickinson France | Injector shield |
| USD938024S1 (en) * | 2020-02-03 | 2021-12-07 | Becton Dickinson France | Injector shield |
| US11904149B1 (en) | 2020-02-18 | 2024-02-20 | Jonathan Vitello | Oral tamper evident closure with retained indicator |
| US11523970B1 (en) | 2020-08-28 | 2022-12-13 | Jonathan Vitello | Tamper evident shield |
| WO2022051470A1 (en) * | 2020-09-02 | 2022-03-10 | Nephron Pharmaceuticals Corporation | Tamper-evident cap |
| JP2024500319A (en) | 2020-12-07 | 2024-01-09 | アイシーユー・メディカル・インコーポレーテッド | Peritoneal dialysis cap, system, and method |
| US12070591B1 (en) | 2020-12-14 | 2024-08-27 | Patrick Vitello | Snap action tamper evident closure assembly |
| US11872187B1 (en) | 2020-12-28 | 2024-01-16 | Jonathan Vitello | Tamper evident seal for a vial cover |
| IT202100003320A1 (en) * | 2021-02-15 | 2022-08-15 | Platinum Pharma Service S R L S | SYRINGE CAP WITH LUER-LOCK ATTACHMENT |
| US12172803B1 (en) | 2021-10-04 | 2024-12-24 | Patrick Vitello | Tamper evident integrated closure |
| WO2023176064A1 (en) * | 2022-03-18 | 2023-09-21 | テルモ株式会社 | Outer cylinder for syringe, syringe, and prefilled syringe |
| EP4316550A1 (en) * | 2022-08-04 | 2024-02-07 | Becton Dickinson France | Tip cap assembly for an injection system |
| KR102648195B1 (en) | 2023-08-09 | 2024-03-15 | (주)이젠텍 | Openable cap |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244480A (en) * | 1979-06-07 | 1981-01-13 | Teco Iberica, S.A. | Cap for sealing containers |
| US20050051508A1 (en) * | 2003-02-27 | 2005-03-10 | Weener Plastik Gmbh & Co. Kg. | Closure cap |
| US20060178627A1 (en) * | 2004-05-29 | 2006-08-10 | Bünder Glas GmbH | Syringe tip cap and method for producing a syringe tip cap |
| US20110174647A1 (en) * | 2008-02-19 | 2011-07-21 | Arte Corporation | Combined container-syringe |
| US8353869B2 (en) * | 2010-11-02 | 2013-01-15 | Baxa Corporation | Anti-tampering apparatus and method for drug delivery devices |
| US20130085453A1 (en) * | 2011-09-30 | 2013-04-04 | Becton Dickinson France, S.A.S. | Syringe Having a Squeeze-Fit Plunger Rod |
Family Cites Families (300)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2723041A (en) | 1951-04-09 | 1955-11-08 | Hart-Still Sydney Charles | Closure for bottles and other containers |
| US2812763A (en) | 1956-07-17 | 1957-11-12 | Becton Dickinson Co | Syringe assembly |
| US3055363A (en) | 1959-11-18 | 1962-09-25 | Becton Dickinson Co | Hypodermic syringe barrel assembly |
| US3112747A (en) | 1961-02-07 | 1963-12-03 | Pharmaseal Lab | Protector |
| DK108590C (en) | 1964-05-28 | 1968-01-08 | Novo Terapeutisk Labor As | Spray ampoule. |
| US3380448A (en) | 1964-11-24 | 1968-04-30 | Abbott Lab | Cervical-pudendal indwelling catheter set with tissue piercing means |
| US3381813A (en) | 1965-09-07 | 1968-05-07 | Pharmaseal Lab | Hypodermic needle and protector therefor |
| US3390759A (en) | 1967-05-25 | 1968-07-02 | Becton Dickinson Co | Shield and hub for disposable needle |
| US3847183A (en) | 1972-11-22 | 1974-11-12 | V Meyer | Closure |
| US3865236A (en) | 1973-03-16 | 1975-02-11 | Becton Dickinson Co | Needle shield |
| DE2434046C3 (en) | 1974-07-16 | 1979-10-18 | Lothar 7500 Karlsruhe Schwarz | Needle holder for medical syringes |
| US4240427A (en) | 1978-10-23 | 1980-12-23 | American Hospital Supply Corporation | Needle with protector |
| US4240425A (en) | 1978-10-23 | 1980-12-23 | American Hospital Supply Corporation | Syringe with plug type needle hub lock |
| DK148782C (en) | 1980-10-31 | 1986-04-21 | Radiometer As | PROCEDURE AND CLOSURE CAP FOR ANAEROBIC SEALING OF A BLOOD TEST CAPILLAR |
| FI832099A7 (en) | 1982-06-15 | 1983-12-16 | Intermedicat Gmbh | Aeration filter. |
| US4452473A (en) | 1982-07-26 | 1984-06-05 | Baxter Travenol Laboratories, Inc. | Luer connection system |
| US4597758A (en) | 1982-09-21 | 1986-07-01 | Baxter Travenol Laboratories, Inc. | Sealing closure for a Luer fitting in open communication with a pressurized liquid supply |
| SE437348B (en) | 1983-07-29 | 1985-02-25 | Pharmacia Ab | CLOSING DEVICE FOR THE FLUID DUMP CONNECTION OF AN OPENING OF A FLUIDUM CONTAINER OR FLUIDUM PIPE |
| WO1988000479A1 (en) | 1986-07-11 | 1988-01-28 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensbur | Syringe for medicinal purposes |
| US4753345A (en) | 1984-06-14 | 1988-06-28 | American Home Products Corporation | Hypodermic syringe tray |
| US4836397A (en) | 1984-11-13 | 1989-06-06 | Baxter International Inc. | Closure for sealing a port |
| DE3515665C1 (en) | 1985-05-02 | 1986-05-15 | Gerhard 6393 Wehrheim Pfetzing | Closure plug |
| US4826490A (en) | 1985-07-29 | 1989-05-02 | National Research Development Corporation | Safety device for hypodermic needle or the like |
| US4636201A (en) | 1985-11-01 | 1987-01-13 | American Hospital Supply Corporation | Hypodermic syringe having a protective sheath cover |
| US4718463A (en) | 1985-12-20 | 1988-01-12 | Mallinckrodt, Inc. | Method of producing prefilled sterile plastic syringes |
| US4628969A (en) | 1985-12-20 | 1986-12-16 | Mallinckrodt, Inc. | Method of producing prefilled sterile plastic syringes |
| US4735311A (en) | 1986-04-09 | 1988-04-05 | The West Company | Needle shield assembly |
| US4765588A (en) | 1986-08-18 | 1988-08-23 | Vernay Laboratories, Inc. | Check valve for use with a syringe |
| US4850970A (en) | 1987-03-26 | 1989-07-25 | American Home Products, Corp. | Two part mastitis cannula cap |
| GB2249727A (en) | 1989-11-16 | 1992-05-20 | Duoject Inc | Syringe vial |
| DE8817024U1 (en) | 1987-09-25 | 1991-12-12 | Industrie Borla S.p.A., Moncalieri, Turin/Torino | Gas-tight closure device for the connecting ends of tubes for biomedical fluid transport devices, in particular haemodialytic chains, which are sterilized by means of sterilizing gas |
| US4935012A (en) | 1988-06-10 | 1990-06-19 | George R. Magre | Safety device for medical needles |
| US4915704A (en) | 1988-06-27 | 1990-04-10 | Terumo Kabushiki Kaisha | Tube assembly with a breakaway plug |
| JP2505871B2 (en) | 1988-11-14 | 1996-06-12 | 株式会社ニッショー | Communication tool when used |
| US4892222A (en) | 1988-11-25 | 1990-01-09 | Baxter International Inc. | Port assembly for a container |
| US5009640A (en) | 1989-01-19 | 1991-04-23 | The Upjohn Company | Slip cap for cannula use |
| US5104379A (en) * | 1989-04-03 | 1992-04-14 | Olympus Optical Co., Ltd. | Medical instrument and valve to be mounted on a mount piece of that instrument |
| ATE108675T1 (en) * | 1989-05-17 | 1994-08-15 | Vetter & Co Apotheker | SYRINGE FOR MEDICAL PURPOSES. |
| US4986818A (en) | 1990-03-30 | 1991-01-22 | Becton, Dickinson And Company | Syringe assembly |
| US5184742A (en) * | 1990-06-18 | 1993-02-09 | Boc Health Care, Inc. | Deadender cap for luer fitting |
| US5125415A (en) | 1990-06-19 | 1992-06-30 | Smiths Industries Medical Systems, Inc. | Syringe tip cap with self-sealing filter |
| US5088995A (en) | 1990-06-22 | 1992-02-18 | Baxter International Inc. | Port and closure assembly including a resealing injection site for a container |
| US5167642A (en) | 1990-08-27 | 1992-12-01 | Baxter International Inc. | Sheath for a blunt cannula |
| DK228290D0 (en) | 1990-09-21 | 1990-09-21 | Novo Nordisk As | AND INJECTION UNIT |
| US5069424A (en) | 1990-10-17 | 1991-12-03 | Itt Corporation | Quick connector |
| US5098400A (en) | 1991-02-14 | 1992-03-24 | Sherwood Medical Company | Needle shield |
| DE9105229U1 (en) | 1991-04-27 | 1991-06-13 | B. Braun Melsungen Ag, 3508 Melsungen | Valve device for a catheter |
| US5224515A (en) | 1992-01-30 | 1993-07-06 | Porex Technologies Corp. | Tube closure |
| US5593391A (en) | 1992-02-13 | 1997-01-14 | Stanners; Sydney D. | Ampule safety syringe |
| AR246435A1 (en) | 1992-08-20 | 1994-08-31 | Moreno Saul | Disposable syringe for use with a needle sheath. |
| US5509911A (en) | 1992-11-27 | 1996-04-23 | Maxxim Medical, Inc. | Rotating adapter for a catheterization system |
| US5373684A (en) | 1992-12-14 | 1994-12-20 | Mallinckrodt Medical, Inc. | Process and apparatus used in producing prefilled, sterile delivery devices |
| WO1994023775A1 (en) | 1993-03-23 | 1994-10-27 | Abbott Laboratories | Securing collar for cannula connector |
| US5540666A (en) | 1993-03-31 | 1996-07-30 | Immuno Aktiengesellschaft | Cannula shield and injection syringe system |
| US5591143A (en) | 1993-04-02 | 1997-01-07 | Medrad Inc. | Luer connector with torque indicator |
| US5395348A (en) | 1993-05-04 | 1995-03-07 | Symbiosis Corporation | Medical intravenous administration line connectors |
| DE4318101A1 (en) | 1993-06-01 | 1994-12-08 | Sterimed Gmbh | Hose coupling |
| DE69429306T2 (en) | 1993-07-09 | 2002-10-17 | Terumo K.K., Tokio/Tokyo | syringe assembly |
| US5447500A (en) | 1993-09-29 | 1995-09-05 | Sterling Winthrop, Inc. | Collar and cartridge-needle unit assembly |
| US5419775A (en) | 1994-01-18 | 1995-05-30 | Allergan, Inc. | Syringe flange adapter and method |
| JP2901483B2 (en) | 1994-03-16 | 1999-06-07 | 株式会社アルテ | Syringe |
| US7033339B1 (en) | 1998-05-29 | 2006-04-25 | Becton Dickinson And Company (Part Interest) | Self sealing luer receiving stopcock |
| JP3383966B2 (en) | 1994-05-27 | 2003-03-10 | ニプロ株式会社 | Prefilled syringe |
| ZA958073B (en) | 1994-09-28 | 1996-04-23 | Anthony William Manicom | Method of and apparatus for administering a drug to a patient |
| DE4434644C2 (en) | 1994-09-28 | 1997-08-07 | Schott Glaswerke | Container for the storage and administration of injection, infusion and diagnostic preparations |
| AUPM922394A0 (en) | 1994-11-03 | 1994-11-24 | Astra Pharmaceuticals Pty Ltd | Plastic syringe with overcap |
| US6196998B1 (en) | 1994-12-12 | 2001-03-06 | Becton Dickinson And Company | Syringe and tip cap assembly |
| US5624402A (en) | 1994-12-12 | 1997-04-29 | Becton, Dickinson And Company | Syringe tip cap |
| JP3208525B2 (en) | 1995-01-05 | 2001-09-17 | 電気化学工業株式会社 | Sodium hyaluronate solution injection and container for injection |
| US5531710A (en) | 1995-02-24 | 1996-07-02 | Courtaulds Aerospace, Inc. | Combination closure and syringe |
| US5658254A (en) | 1995-03-31 | 1997-08-19 | Becton, Dickinson And Company | Syringe having safety needle shield |
| IT235830Y1 (en) | 1995-04-06 | 2000-07-18 | Borla Ind | "LUER-LOCK FITTING WITH PROTECTION CAP FOR MEDICATION LINES-INFUSION-TRANSFUSION." |
| US5607400A (en) | 1995-05-19 | 1997-03-04 | Becton, Dickinson And Company | Pre-fillable syringe and stopper assembly therefor |
| JP3647958B2 (en) | 1995-06-16 | 2005-05-18 | 株式会社アルテ | Container / Syringe |
| US5807345A (en) | 1995-06-30 | 1998-09-15 | Abbott Laboratories | Luer cap for terminally sterilized syringe |
| US5693025A (en) | 1995-07-14 | 1997-12-02 | Merit Medical Systems, Inc. | Adapter with hemostasis valve and rotatable connector |
| DE19547431A1 (en) * | 1995-12-05 | 1997-06-12 | Schering Ag | Closure system for a sterile syringe |
| US5836919A (en) | 1996-05-23 | 1998-11-17 | Solopak Pharmaceuticals, Inc. | Cap assembly |
| SE513823C2 (en) | 1996-05-31 | 2000-11-13 | Wiklund Ernst S G F | Point guard for puncture needles |
| US5820604A (en) | 1996-06-11 | 1998-10-13 | Endolap, Inc. | Cannula cap including yeildable outer seal and flapper valve |
| US5858008A (en) | 1997-04-22 | 1999-01-12 | Becton, Dickinson And Company | Cannula sealing shield assembly |
| US20020013556A1 (en) | 1996-11-18 | 2002-01-31 | Cote Andrew L. | Swabbable luer-activated valve |
| US7789864B2 (en) | 1996-11-18 | 2010-09-07 | Nypro Inc. | Luer-activated valve |
| DE19652708C2 (en) | 1996-12-18 | 1999-08-12 | Schott Glas | Process for producing a filled plastic syringe body for medical purposes |
| CA2227942A1 (en) | 1997-01-31 | 1998-07-31 | Becton, Dickinson And Company | Adapter for mounting a fluid handling device on a catheter tubing |
| JP3380705B2 (en) | 1997-03-12 | 2003-02-24 | 株式会社大協精工 | Sealed rubber stopper for syringe and container |
| US5820621A (en) | 1997-07-29 | 1998-10-13 | Becton, Dickinson And Company | Medical fluid transfer and delivery device |
| US6029946A (en) | 1997-09-15 | 2000-02-29 | Tiva Medical Inc. | Needleless valve |
| US6004296A (en) | 1997-09-30 | 1999-12-21 | Becton Dickinson France, S.A. | Lockable safety shield assembly for a prefillable syringe |
| DE19751219A1 (en) | 1997-11-19 | 1999-05-27 | Vetter & Co Apotheker | Syringe, especially prefilled syringe, or carpule |
| DE69928926T2 (en) | 1998-03-27 | 2006-08-24 | Bracco International B.V. | SYNTHETIC PLASTIC CYLINDERS AND METHOD FOR ITS IMPROVEMENT |
| US6361524B1 (en) | 1998-04-14 | 2002-03-26 | Becton, Dickinson And Company | Syringe assembly |
| DE69925205T2 (en) | 1998-07-31 | 2006-03-09 | Becton, Dickinson And Co. | Needle guard for prefilled syringe |
| US6261270B1 (en) | 1998-09-23 | 2001-07-17 | Abbott Laboratories | Sleeve stopper |
| US6394983B1 (en) | 1998-10-28 | 2002-05-28 | Abbott Laboratories | Cap and luer connector for a fluid transfer device |
| DE19909824A1 (en) | 1999-03-05 | 2000-09-07 | Vetter & Co Apotheker | Syringe for medical purposes and assembly method |
| US6716396B1 (en) | 1999-05-14 | 2004-04-06 | Gen-Probe Incorporated | Penetrable cap |
| US6706022B1 (en) | 1999-07-27 | 2004-03-16 | Alaris Medical Systems, Inc. | Needleless medical connector with expandable valve mechanism |
| DE19954373B4 (en) | 1999-11-11 | 2011-01-27 | Helvoet Pharma Belgium N.V. | Protective cap for a cannula |
| US6652509B1 (en) | 2000-04-03 | 2003-11-25 | Abbott Laboratories | Housing capable of connecting a container to a medical device |
| US6632199B1 (en) | 2000-05-23 | 2003-10-14 | Becton Dickinson And Company | Syringe assembly including plastic tip cap |
| US6569118B2 (en) | 2000-05-25 | 2003-05-27 | Johnnie M. Johnson | Adapter and method of attachment for “LUER LOK” receptacles |
| US6375022B1 (en) | 2000-06-30 | 2002-04-23 | Becton, Dickinson And Company | Resealable closure for containers |
| US7316669B2 (en) | 2002-08-22 | 2008-01-08 | Baxa Corporation | Protective cap for medical male luer fittings |
| DE50000940D1 (en) | 2000-09-27 | 2003-01-23 | Schering Ag | Syringe with a cylinder holding a fluid medium and a closure cap |
| JP2002153539A (en) | 2000-11-16 | 2002-05-28 | Asahi Medical Co Ltd | Lure plug body for medical instrument and medical instrument with the same |
| FR2816848B1 (en) | 2000-11-17 | 2003-06-20 | Rumpler Technologies | PROTECTION DEVICE FOR SYRINGE NEEDLE |
| US20050187524A1 (en) | 2000-12-19 | 2005-08-25 | Willis Allan F. | Sealing valve assembly for medical products |
| US6595964B2 (en) | 2000-12-22 | 2003-07-22 | Baxter International Inc. | Luer activated thread coupler |
| US7316679B2 (en) | 2001-01-22 | 2008-01-08 | Venetec International, Inc. | Medical device connector fitting |
| US6585691B1 (en) | 2001-05-11 | 2003-07-01 | Jonathan J. Vitello | Tamper evident end cap assembly for a loaded syringe and process |
| DE10127779A1 (en) * | 2001-06-01 | 2002-12-12 | Vetter & Co Apotheker | Twist closure for primary packaging of pharmaceuticals, comprising channels between closure parts to allow flow of sterilizing vapor to closure contact surfaces |
| JP2003054615A (en) | 2001-06-07 | 2003-02-26 | Sumitomo Pharmaceut Co Ltd | Winding lid and container using the same |
| GB2410305B (en) | 2001-09-04 | 2005-12-07 | Clinical Product Dev Ltd | Couplings for medical fluid delivery systems |
| US7563249B2 (en) | 2002-12-20 | 2009-07-21 | Medrad, Inc. | Syringe having an alignment flange, an extending lip and a radial expansion section of reduced wall thickness |
| US6802490B2 (en) | 2001-11-29 | 2004-10-12 | Alaris Medical Systems, Inc. | Needle free medical connector with expanded valve mechanism and method of fluid flow control |
| FR2833175B1 (en) | 2001-12-06 | 2004-05-14 | Sobem | FLOW CONTROL DEVICE FOR MEDICAL USE |
| US6651956B2 (en) | 2002-01-31 | 2003-11-25 | Halkey-Roberts Corporation | Slit-type swabable valve |
| US6821267B2 (en) | 2002-03-07 | 2004-11-23 | Baxter International | Luer tip cap having reduced removal force |
| FR2836832B1 (en) | 2002-03-08 | 2005-02-04 | Optis France Sa | CONNECTION ASSEMBLY FOR MEDICAL USE FOR THE TRANSFER OF FLUIDS |
| US7244249B2 (en) | 2002-05-08 | 2007-07-17 | Cardinal Health 303, Inc. | Needle-free medical connector with expandable valve mechanism and method of fluid flow control |
| JP4427965B2 (en) | 2002-07-02 | 2010-03-10 | ニプロ株式会社 | Chemical container with communication means |
| ITTO20020668A1 (en) | 2002-07-26 | 2004-01-26 | Borla Ind | CANNULA WITH PROTECTION CAP FOR MEDICAL INFUSION LINES |
| CA2638781C (en) | 2002-09-03 | 2010-02-02 | Medical Instill Technologies, Inc. | Sealed containers and methods of making and filling same |
| US8377039B2 (en) | 2002-10-04 | 2013-02-19 | Nxstage Medical, Inc. | Injection site for male luer or other tubular connector |
| US7056308B2 (en) | 2002-10-04 | 2006-06-06 | Dsu Medical Corporation | Medical device with elastomeric penetrable wall and inner seal |
| DE10247965A1 (en) | 2002-10-15 | 2004-05-06 | Transcoject Gesellschaft für medizinische Geräte mbH & Co KG | Tamper-evident closure for a syringe |
| DE10247963A1 (en) | 2002-10-15 | 2004-05-06 | Transcoject Gesellschaft für medizinische Geräte mbH & Co KG | Pre-filled syringe with membrane seal, has cylinder, connector and sealing membrane constructed in one piece as plastic injection-molded part |
| GB0224505D0 (en) | 2002-10-22 | 2002-11-27 | Medical House The Plc | Needles injection device |
| JP4522071B2 (en) | 2002-10-24 | 2010-08-11 | テルモ株式会社 | Syringe |
| JP4491215B2 (en) | 2003-10-06 | 2010-06-30 | テルモ株式会社 | Prefilled syringe and method for producing prefilled syringe |
| JP4064422B2 (en) | 2003-01-09 | 2008-03-19 | フカイ工業株式会社 | Seal valve for medical device, connection port, mixed injection tube, infusion circuit connection device, and infusion circuit connection system |
| US7338474B2 (en) * | 2003-02-18 | 2008-03-04 | Tribute Technologies, Llc | Luer attachment for syringe safety |
| US7118560B2 (en) | 2003-02-28 | 2006-10-10 | Creative Plastic Technology, Llc | Needleless Luer activated medical connector |
| USD493526S1 (en) | 2003-04-22 | 2004-07-27 | Becton, Dickinson And Company | Syringe tip cap |
| DE10340613A1 (en) | 2003-08-29 | 2005-03-24 | Primojex Gmbh | Device for injecting an injectable product |
| US20050063857A1 (en) | 2003-09-23 | 2005-03-24 | Alheidt Thomas A. | Flush syringe having anti-reflux stopper |
| US20050075611A1 (en) | 2003-10-01 | 2005-04-07 | Hetzler Kevin G. | Low extractable, thermoplastic syringe and tip cap |
| US20060129109A1 (en) | 2003-10-28 | 2006-06-15 | Scott Randall Shaw | Reconnectable disconnect device for fluid transfer line |
| HK1077154A2 (en) | 2003-12-30 | 2006-02-03 | Icu Medical, Inc. | Valve assembly |
| US7497843B1 (en) | 2004-03-12 | 2009-03-03 | Medrad, Inc. | Syringe interfaces, syringe adapters and injector systems |
| US7815606B2 (en) | 2004-04-23 | 2010-10-19 | Coeur, Inc. | Syringe adapter system and method of cleaning the adapter |
| US20140276459A1 (en) | 2013-03-13 | 2014-09-18 | Jonathan Yeh | Needleless connector with folding valve |
| MX2007005324A (en) | 2004-11-05 | 2007-06-25 | Icu Medical Inc | Soft-grip medical connector. |
| DE102004055453A1 (en) | 2004-11-17 | 2006-05-24 | Schering Ag | originality closure |
| US7645274B2 (en) | 2004-12-10 | 2010-01-12 | Cardinal Health 303, Inc. | Self-sealing male luer connector with multiple seats |
| US7396051B2 (en) | 2005-01-14 | 2008-07-08 | Baxa Corporation | Swabable fluid connectors and fluid connector pairs |
| PL1848913T3 (en) | 2005-02-14 | 2013-12-31 | Borla Ind | Valved fluid connector |
| WO2006096960A1 (en) | 2005-03-15 | 2006-09-21 | Vasogen Ireland Limited | Controlled flow adapter for medical fluid containers |
| ATE413895T1 (en) | 2005-03-24 | 2008-11-15 | Disetronic Licensing Ag | DEVICE FOR THE DOSED ADMINISTRATION OF A FLUID PRODUCT |
| US20070088294A1 (en) | 2005-07-06 | 2007-04-19 | Fangrow Thomas F Jr | Medical connector with closeable male luer |
| US7998134B2 (en) | 2007-05-16 | 2011-08-16 | Icu Medical, Inc. | Medical connector |
| US20080249479A1 (en) | 2005-08-01 | 2008-10-09 | Medimop Medical Projects Ltd. | Liquid Drug Delivery System |
| EP1759729B1 (en) | 2005-08-30 | 2009-12-23 | Cilag GmbH International | Needle assembly for a prefilled syringe system |
| JP4555766B2 (en) * | 2005-10-19 | 2010-10-06 | 株式会社アルテ | Container / Syringe |
| JP4943690B2 (en) | 2005-10-27 | 2012-05-30 | 前田産業株式会社 | Syringe holder and syringe |
| DE102005052545A1 (en) | 2005-11-02 | 2007-05-03 | Schering Ag | Closure for medical syringe, has syringe cylinder and connected syringe neck at distal end whereby syringe neck has fixable adapter in which screw cap is fixable |
| DE102005054075A1 (en) | 2005-11-12 | 2007-05-16 | Vetter & Co Apotheker | Needle attachment for a syringe or carpule |
| US8377010B2 (en) | 2005-11-17 | 2013-02-19 | Becton, Dickinson And Company | Medical access device |
| FR2896168B1 (en) | 2006-01-19 | 2008-10-17 | Aguettant Soc Par Actions Simp | PRE-FILLED HYPODERMIC SYRINGE EQUIPPED WITH A CLOGGING DEVICE |
| US20070225647A1 (en) | 2006-03-23 | 2007-09-27 | Luther Ronald B | Flush entrance hemostasis valve with unobstructed passageway |
| JP5161457B2 (en) | 2006-04-03 | 2013-03-13 | 日本コヴィディエン株式会社 | Male luer connector |
| US9295790B2 (en) | 2006-05-05 | 2016-03-29 | Retractable Technologies, Inc. | Syringe with recessed nose and protective guard for use with frontal attachments |
| US8162899B2 (en) | 2006-05-18 | 2012-04-24 | Hyprotek, Inc. | Intravascular line and port cleaning methods, methods of administering an agent intravascularly, methods of obtaining/testing blood, and devices for performing such methods |
| GB2438593B (en) | 2006-06-01 | 2011-03-30 | Cilag Gmbh Int | Injection device (cap removal feature) |
| US9958067B2 (en) | 2006-06-13 | 2018-05-01 | Nordson Corporation | Liquid dispensing syringe |
| US8167847B2 (en) | 2006-06-22 | 2012-05-01 | Excelsior Medical Corporation | Antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly |
| US8038182B2 (en) | 2006-07-18 | 2011-10-18 | Mallinckrodt Llc | Breakage resistant fitting |
| US10881847B2 (en) | 2006-08-09 | 2021-01-05 | Lawrence Allan Lynn | Neutral pressure split septum luer access device |
| US7632244B2 (en) * | 2006-08-10 | 2009-12-15 | Comar, Inc. | Tamper evident tip cap assembly |
| US7753338B2 (en) | 2006-10-23 | 2010-07-13 | Baxter International Inc. | Luer activated device with minimal fluid displacement |
| JP4895767B2 (en) | 2006-11-15 | 2012-03-14 | 株式会社アルテ | Luer lock tube tip of syringe |
| JP2008125560A (en) | 2006-11-16 | 2008-06-05 | Daikyo Seiko Ltd | Syringe nozzle cap |
| FR2910817B1 (en) | 2007-01-03 | 2009-02-13 | Vygon Sa | CONNECTOR FOR ESTABLISHING A FLUID COMMUNICATION UNDER THE CONTROL OF A VALVE, IN PARTICULAR FOR USE IN THE MEDICAL FIELD |
| US8172825B2 (en) | 2007-01-16 | 2012-05-08 | The University Of Utah Research Foundation | Methods for disinfecting medical connectors |
| US8328767B2 (en) | 2007-01-16 | 2012-12-11 | Catheter Connections, Inc. | Disinfecting caps for medical male luer connectors |
| US8523830B2 (en) | 2007-01-16 | 2013-09-03 | Catheter Connections | Disinfecting caps for medical female luer connectors |
| US7935091B2 (en) | 2007-01-16 | 2011-05-03 | Bousquet Gerald G | Catheter extension set and closure assembly therefor |
| US9259284B2 (en) | 2007-02-12 | 2016-02-16 | 3M Innovative Properties Company | Female Luer connector disinfecting cap |
| FR2913200B1 (en) | 2007-03-02 | 2009-12-11 | Becton Dickinson France | NEEDLE PROTECTION DEVICE |
| WO2008110014A1 (en) | 2007-03-13 | 2008-09-18 | 0736413 B.C. Ltd. | Disinfectant cap for sterile liquid dispenser |
| USD588693S1 (en) | 2007-06-12 | 2009-03-17 | Nordson Corporation | Liquid dispensing syringe |
| USD581046S1 (en) | 2007-06-25 | 2008-11-18 | Daikyo Seiko, Ltd. | Nozzle cap for syringe |
| USD581049S1 (en) | 2007-06-25 | 2008-11-18 | Daikyo Seiko, Ltd. | Nozzle cap for syringe |
| CA2639320C (en) | 2007-09-07 | 2016-10-25 | Becton, Dickinson And Company | Pen-needle assembly for preventing under-torquing and over-torquing of pen-needle |
| US20090069757A1 (en) | 2007-09-08 | 2009-03-12 | Medco International, Llc | Elastomeric seal for use within a catheter component |
| ITTO20070141U1 (en) | 2007-11-14 | 2009-05-15 | Borla Ind | SYRINGE |
| AT505616B1 (en) | 2008-02-07 | 2009-03-15 | Pickhard Brigitte | INJECTION sYRINGE |
| JP2009219855A (en) | 2008-02-19 | 2009-10-01 | Arte Corp | Syringe-cum-container |
| DE102008013198B4 (en) | 2008-03-07 | 2011-07-14 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Tamper evident closure with retaining pin |
| JP5283417B2 (en) | 2008-03-31 | 2013-09-04 | テルモ株式会社 | Cap and prefilled syringe manufacturing method |
| JP5265666B2 (en) | 2008-04-01 | 2013-08-14 | 生化学工業株式会社 | Chemical liquid discharge part sealing cap |
| SI2138202T1 (en) | 2008-06-23 | 2010-07-30 | Logica | Connecting part for connecting with a standardised luer lock connection |
| WO2010017161A2 (en) | 2008-08-04 | 2010-02-11 | Np Medical Inc. | Medical valve with raised seal |
| EP2151319A1 (en) | 2008-08-08 | 2010-02-10 | PolyCine GmbH | Plug to seal a medicinal system |
| WO2010024209A1 (en) | 2008-08-25 | 2010-03-04 | 電気化学工業株式会社 | Syringe |
| BRPI0823117B8 (en) | 2008-09-29 | 2021-06-22 | Vifor Int Ag | receptacle and method for storing and supplying a liquid and a liquid medical preparation |
| WO2010034356A1 (en) | 2008-09-29 | 2010-04-01 | Vifor (International) Ag | Cap assembly and production method |
| US9078992B2 (en) * | 2008-10-27 | 2015-07-14 | Pursuit Vascular, Inc. | Medical device for applying antimicrobial to proximal end of catheter |
| WO2010059345A2 (en) | 2008-11-18 | 2010-05-27 | B. Braun Melsungen Ag | Hinged cap for needle device |
| JP2010131064A (en) | 2008-12-02 | 2010-06-17 | Arte Corp | Container-cum-syringe |
| US8790330B2 (en) | 2008-12-15 | 2014-07-29 | Carmel Pharma Ab | Connection arrangement and method for connecting a medical device to the improved connection arrangement |
| DE102009007250A1 (en) | 2009-01-26 | 2010-07-29 | Arzneimittel Gmbh Apotheker Vetter & Co. Ravensburg | syringe |
| CN102307604B (en) | 2009-02-07 | 2016-02-10 | 美国医疗设备有限公司 | Band valve connector |
| US8361038B2 (en) | 2009-02-11 | 2013-01-29 | Becton, Dickinson And Company | Systems and methods for providing a flow control valve for a medical device |
| JP2010214096A (en) | 2009-02-19 | 2010-09-30 | Jms Co Ltd | Medical needle device |
| CN104613232B (en) | 2009-03-22 | 2018-02-09 | 爱康医学农业合作协会有限公司 | The public luer connector of closure |
| US8454579B2 (en) | 2009-03-25 | 2013-06-04 | Icu Medical, Inc. | Medical connector with automatic valves and volume regulator |
| US8888756B2 (en) | 2009-03-30 | 2014-11-18 | Gto Ltd. | Plug for container |
| US8182452B2 (en) | 2009-04-06 | 2012-05-22 | Carefusion 303, Inc. | Closed male luer device for use with needleless access devices |
| GB0906640D0 (en) | 2009-04-17 | 2009-06-03 | Owen Mumford Ltd | A needle cap assembly |
| DE102009019340A1 (en) | 2009-04-30 | 2010-11-04 | Transcoject Gmbh & Co. Kg | Luer lock connector |
| US8790313B2 (en) | 2009-06-17 | 2014-07-29 | Unitract Syringe Pty Ltd | Syringe adapter |
| US7955317B2 (en) | 2009-06-30 | 2011-06-07 | Tyco Healthcare Group Lp | Female adaptor for feeding line |
| USD638123S1 (en) | 2009-07-10 | 2011-05-17 | Becton, Dickinson And Company | Syringe plunger rod |
| US8277424B2 (en) | 2009-07-17 | 2012-10-02 | Pan Hsiu-Feng | Needle-less syringe adapter |
| US8715247B2 (en) | 2009-07-30 | 2014-05-06 | Carefusion 303, Inc. | Collapsible valve |
| USD629895S1 (en) | 2009-08-14 | 2010-12-28 | Carl Zeiss Surgical Gmbh | Handhold for medical instruments |
| US20110184382A1 (en) | 2009-08-20 | 2011-07-28 | Cady Timothy B | Multi-purpose articles for sanitizing and capping luer access valves |
| US9149624B2 (en) * | 2009-09-02 | 2015-10-06 | Carefusion 303, Inc. | Disinfecting male luer connector caps |
| IL202069A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Fluid transfer device with sealing arrangement |
| US8636720B2 (en) | 2009-11-16 | 2014-01-28 | Carefusion 303, Inc. | Needleless access connectors and valve elements therefor |
| WO2011066565A1 (en) * | 2009-11-30 | 2011-06-03 | Catheter Connections, Inc. | Disinfecting caps having an extendable feature and related systems and methods |
| WO2011066586A1 (en) | 2009-11-30 | 2011-06-03 | Catheter Connections, Inc. | Disinfecting caps having sealing features and related systems and methods |
| USD632389S1 (en) | 2010-01-14 | 2011-02-08 | Sumitomo Rubber Industries, Ltd. | Gasket for injector |
| EP2347750A1 (en) | 2010-01-26 | 2011-07-27 | Fresenius Kabi Deutschland GmbH | Connector for containers containing medical agents |
| CN102858390B (en) | 2010-03-12 | 2015-12-02 | Sid科技有限责任公司 | Components used with the syringe |
| US20130012886A1 (en) | 2010-03-18 | 2013-01-10 | Daikyo Seiko, Ltd. | Syringe needle cap |
| US8298196B1 (en) | 2010-03-24 | 2012-10-30 | Mansour George M | Needleless access connector and method of use |
| JPWO2011125475A1 (en) | 2010-03-31 | 2013-07-08 | テルモ株式会社 | Syringe |
| JP5519375B2 (en) | 2010-04-01 | 2014-06-11 | 義則 出野 | Automatic antenna tuning and matching device |
| JP5683129B2 (en) | 2010-04-30 | 2015-03-11 | 大和特殊硝子株式会社 | Vial stopper and seal member used therefor |
| ES2493515T3 (en) * | 2010-05-06 | 2014-09-11 | Icu Medical, Inc. | Medical connector with pluggable Luer type connection |
| US8348895B1 (en) | 2010-05-27 | 2013-01-08 | Medical Device Engineering, LLC. | Tamper evident cap assembly |
| US8257322B2 (en) | 2010-06-02 | 2012-09-04 | Smiths Medical Asd, Inc. | Tip protector for a safety catheter |
| US8721627B2 (en) | 2010-07-22 | 2014-05-13 | Carefusion 303, Inc. | Needleless valve infection prevention and pre-opening device |
| GB201013137D0 (en) | 2010-08-04 | 2010-09-22 | Obrist Closures Switzerland | A closure |
| US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
| FR2967655B1 (en) | 2010-11-24 | 2014-03-14 | Biocorp Rech Et Dev | DEVICE FOR CLOSING A CONTAINER, CONTAINER EQUIPPED WITH SUCH A DEVICE AND METHOD FOR CLOSING A BATCH OF SUCH CONTAINERS |
| DE102010061061A1 (en) | 2010-12-07 | 2012-06-14 | Alfred Von Schuckmann | syringe cap |
| WO2012079180A1 (en) | 2010-12-14 | 2012-06-21 | Hoffmann Neopac Ag | Tube with a female luer lock fitting |
| US8603047B2 (en) | 2010-12-15 | 2013-12-10 | Infusion Innovations | Devices, assemblies and methods for controlling fluid flow |
| USD665498S1 (en) | 2011-01-11 | 2012-08-14 | Fuso Pharmaceutical Industries, Ltd. | Gasket for injector |
| WO2012098503A1 (en) | 2011-01-18 | 2012-07-26 | Nanopass Technologies Ltd. | Medication delivery assembly |
| JP2014508601A (en) | 2011-03-03 | 2014-04-10 | フェッター ファルマ−フェルティグング ゲーエムベーハー ウント コンパニー カーゲー | Seal plug for syringe and manufacturing method |
| US8544665B2 (en) | 2011-04-04 | 2013-10-01 | Genesis Packaging Technologies | Cap systems and methods for sealing pharmaceutical vials |
| US9604012B2 (en) | 2011-04-20 | 2017-03-28 | Taisei Kako Co., Ltd. | Barrel with cap, pre-filled syringe, and cap with connector |
| USD720067S1 (en) | 2011-05-02 | 2014-12-23 | Carmel Pharma Ab | Medical device |
| US9867975B2 (en) | 2011-05-23 | 2018-01-16 | Excelsior Medical Corporation | Antiseptic line cap |
| US10166381B2 (en) | 2011-05-23 | 2019-01-01 | Excelsior Medical Corporation | Antiseptic cap |
| USD675729S1 (en) | 2011-05-31 | 2013-02-05 | Hsien-Tsung Wang | Float body for intravenous infusion set |
| FR2975976B1 (en) | 2011-06-06 | 2014-08-29 | Biocorp Rech Et Dev | CLOSURE DEVICE AND CONTAINER EQUIPPED WITH SUCH A DEVICE |
| JP6140916B2 (en) | 2011-06-08 | 2017-06-07 | 株式会社ジェイ・エム・エス | Medical male parts |
| USD688796S1 (en) | 2011-06-14 | 2013-08-27 | Sekisui Medical Co., Ltd. | Cap for a blood collection tube |
| US8832894B2 (en) | 2011-07-19 | 2014-09-16 | Ivera Medical Corporation | Cleaning device for male end of intraveneous set |
| USD677794S1 (en) | 2011-07-29 | 2013-03-12 | Branko Prpa | Table top implant tracking device with a transparent sheath |
| JP2013034567A (en) | 2011-08-05 | 2013-02-21 | Daikyo Seiko Ltd | Plastic-made nozzle cap |
| WO2013047042A1 (en) | 2011-09-26 | 2013-04-04 | テルモ株式会社 | Syringe |
| US8882719B2 (en) | 2011-09-30 | 2014-11-11 | Becton Dickinson France S.A.S. | Syringe having a removable cover for use as a plunger rod in rotational engagement |
| JP5798872B2 (en) | 2011-10-03 | 2015-10-21 | 大成化工株式会社 | Cap, barrel with cap, and prefilled syringe |
| US9155864B2 (en) | 2011-10-06 | 2015-10-13 | Becton, Dickinson And Company | Multiple use blood control valve with center and circumferential slits |
| US9155863B2 (en) | 2011-10-06 | 2015-10-13 | Becton, Dickinson And Company | Multiple use stretching and non-penetrating blood control valves |
| US9358364B2 (en) | 2011-10-06 | 2016-06-07 | Becton, Dickinson And Company | Activator attachment for blood control catheters |
| JP6243096B2 (en) | 2011-11-16 | 2017-12-06 | 株式会社大協精工 | Rubber stopper for vial |
| DE102011120637A1 (en) | 2011-12-09 | 2013-06-13 | Schott Schweiz Ag | Closure, in particular syringe closure for the sealing closing of a distal opening of a syringe body |
| USD720452S1 (en) | 2011-12-15 | 2014-12-30 | Mark Jordan | Syringe connection hub |
| WO2013088087A2 (en) | 2011-12-16 | 2013-06-20 | C.P.A. | Device for capping a bottle |
| US9238128B2 (en) | 2011-12-27 | 2016-01-19 | Nipro Corporation | Needleless connector |
| US8801678B2 (en) | 2012-01-20 | 2014-08-12 | Carefusion 303, Inc. | Piston for a needleless valve system |
| US9114244B2 (en) | 2012-01-27 | 2015-08-25 | Carefusion 303, Inc. | Needleless valve system fluid control |
| EP2809385B1 (en) | 2012-02-01 | 2025-03-05 | Hospi Corporation | Valved enteral administration assembly |
| CN104136068B (en) | 2012-02-13 | 2017-04-05 | 尼普洛株式会社 | Needleless connector |
| DE102012005189A1 (en) | 2012-03-16 | 2013-09-19 | Fresenius Medical Care Deutschland Gmbh | Medical device with a socket unit for connecting a device for providing medical fluids |
| EP2833948B1 (en) | 2012-04-04 | 2016-05-18 | Boehringer Ingelheim International GmbH | Closure system for an applicator projection on a container for pharmaceutical preparations, use, container with closure system, spray for medical purposes, and assembly method |
| US9352119B2 (en) | 2012-05-15 | 2016-05-31 | Becton, Dickinson And Company | Blood control IV catheter with antimicrobial properties |
| US8758307B2 (en) | 2012-06-15 | 2014-06-24 | B. Braun Medical Inc. | Self-priming, anti-free flow valve for infusion pumps |
| ITTO20120575A1 (en) | 2012-06-27 | 2013-12-28 | Borla Ind | UNIDIRECTIONAL VALVE FOR MEDICAL INFUSION AND SIMILAR LINES |
| FR2994392B1 (en) | 2012-08-10 | 2014-08-08 | Cair L G L | CONNECTOR FOR MEDICAL USE |
| US9579486B2 (en) | 2012-08-22 | 2017-02-28 | Becton, Dickinson And Company | Blood control IV catheter with antimicrobial properties |
| US20150217061A1 (en) | 2012-08-22 | 2015-08-06 | Antares Pharma, Inc. | Needle Shield |
| USD710498S1 (en) | 2012-09-24 | 2014-08-05 | Daikyo Seiko, Ltd. | Cap of container for mixing medications |
| ES2599508T3 (en) | 2012-09-26 | 2017-02-02 | Transcoject Gmbh | Prefilled syringe |
| DE102012022008A1 (en) | 2012-11-09 | 2014-05-15 | Vetter Pharma-Fertigung GmbH & Co. KG | syringe closure |
| US8979804B2 (en) | 2012-12-24 | 2015-03-17 | Pacific Hospital Supply Co., Ltd. | Needleless connector |
| USD714935S1 (en) | 2013-01-10 | 2014-10-07 | Fuso Pharmaeutical Industries, Ltd. | Adapter for connecting a needle to a syringe |
| USD733291S1 (en) | 2013-01-15 | 2015-06-30 | Hsien-Tsung Wang | Depressible plug for vial |
| USD732664S1 (en) | 2013-02-25 | 2015-06-23 | B. Braun Melsungen Ag | Proximal catheter hub body |
| US8840577B1 (en) | 2013-03-14 | 2014-09-23 | Carefusion 303, Inc. | Needleless connector with flexible valve |
| US9370651B2 (en) | 2013-03-13 | 2016-06-21 | Carefusion 303, Inc. | Needleless connector with reduced trapped volume |
| US9089682B2 (en) | 2013-03-14 | 2015-07-28 | Carefusion 303, Inc. | Needleless connector with support member |
| US8708976B1 (en) | 2013-03-14 | 2014-04-29 | Carefusion 303, Inc. | Needleless connector with a tortuous fluid flow path |
| USD733293S1 (en) | 2013-03-15 | 2015-06-30 | Rocomp Global, Llc | Energy guide |
| US9227188B2 (en) | 2013-04-11 | 2016-01-05 | Rarecyte, Inc. | Device, system, and method for selecting a target analyte or fluid |
| KR101361088B1 (en) | 2013-07-11 | 2014-02-12 | 조희민 | A syringe with a prevention type pening and closing cap |
| AU353353S (en) | 2013-10-02 | 2014-01-21 | Terumo Corp | Medical syringe |
| EP2862587A1 (en) * | 2013-10-15 | 2015-04-22 | Becton Dickinson France | Tip cap assembly for closing an injection system |
| BR112016011279B1 (en) | 2013-11-18 | 2022-09-06 | Halkey-Roberts Corporation | MEDICAL CONNECTOR ASSEMBLY |
| US9283369B2 (en) | 2014-02-20 | 2016-03-15 | Becton, Dickinson And Company | IV access port cap for providing antimicrobial protection |
| WO2015142850A1 (en) | 2014-03-18 | 2015-09-24 | I-V Access Technology, Inc. | Intravenous catheter with pressure activated valve |
| US10391264B2 (en) | 2014-04-04 | 2019-08-27 | Retractable Technologies, Inc | Medical device with selectively retractable needle cap |
-
2013
- 2013-10-15 EP EP20130306414 patent/EP2862587A1/en not_active Withdrawn
-
2014
- 2014-10-14 US US15/028,950 patent/US11013865B2/en active Active
- 2014-10-14 ES ES20165835T patent/ES2972500T3/en active Active
- 2014-10-14 KR KR1020227016948A patent/KR102591387B1/en active Active
- 2014-10-14 KR KR1020227016942A patent/KR102659029B1/en active Active
- 2014-10-14 KR KR1020167012339A patent/KR102401509B1/en active Active
- 2014-10-14 ES ES20165836T patent/ES2977986T3/en active Active
- 2014-10-14 RU RU2016117809A patent/RU2645240C2/en active
- 2014-10-14 EP EP20165836.6A patent/EP3689399B1/en active Active
- 2014-10-14 EP EP20165835.8A patent/EP3689398B1/en active Active
- 2014-10-14 EP EP20165837.4A patent/EP3689400A1/en active Pending
- 2014-10-14 WO PCT/EP2014/071950 patent/WO2015055608A1/en not_active Ceased
- 2014-10-14 EP EP14789542.9A patent/EP3057633B1/en active Active
- 2014-10-14 JP JP2016524012A patent/JP6700177B2/en active Active
- 2014-10-14 KR KR1020227016949A patent/KR102642889B1/en active Active
- 2014-10-14 ES ES14789542T patent/ES2802925T3/en active Active
- 2014-10-15 CN CN202110409201.7A patent/CN113101461B/en active Active
- 2014-10-15 CN CN201410857906.5A patent/CN104548281A/en active Pending
- 2014-10-15 CN CN202110422798.9A patent/CN113101464B/en active Active
- 2014-10-15 CN CN202111140079.4A patent/CN113842526A/en active Pending
- 2014-10-15 CN CN201420874047.6U patent/CN204798514U/en not_active Withdrawn - After Issue
-
2021
- 2021-04-26 US US17/240,484 patent/US20210244892A1/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244480A (en) * | 1979-06-07 | 1981-01-13 | Teco Iberica, S.A. | Cap for sealing containers |
| US20050051508A1 (en) * | 2003-02-27 | 2005-03-10 | Weener Plastik Gmbh & Co. Kg. | Closure cap |
| US20060178627A1 (en) * | 2004-05-29 | 2006-08-10 | Bünder Glas GmbH | Syringe tip cap and method for producing a syringe tip cap |
| US20110174647A1 (en) * | 2008-02-19 | 2011-07-21 | Arte Corporation | Combined container-syringe |
| US8353869B2 (en) * | 2010-11-02 | 2013-01-15 | Baxa Corporation | Anti-tampering apparatus and method for drug delivery devices |
| US20130085453A1 (en) * | 2011-09-30 | 2013-04-04 | Becton Dickinson France, S.A.S. | Syringe Having a Squeeze-Fit Plunger Rod |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478449B1 (en) | 2019-11-25 | 2025-11-25 | International Medical Industries Inc | Needle packaging and disposal assembly |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210244892A1 (en) | Tip Cap Assembly for Closing an Injection System | |
| US4084588A (en) | Parenteral drug storage device with closure piercing coupling member | |
| US6520935B1 (en) | Syringe and tip cap assembly | |
| CN102281911B (en) | Cover assembly and manufacturing method | |
| US4484916A (en) | Medical solution container and port construction | |
| US4592092A (en) | Medical solution container and port construction therefor | |
| JP2016525395A (en) | Adapter for a drug delivery device and method for mounting the adapter therein | |
| JP6913156B2 (en) | Female syringe and syringe kit | |
| JP4299509B2 (en) | Prefilled syringe and prefilled syringe | |
| EP4316550A1 (en) | Tip cap assembly for an injection system | |
| US20240335621A1 (en) | Closure cap and closure system for a syringe that is prefilled with a medicament or medical active substance |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: BECTON DICKINSON FRANCE, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MARITAN, LIONEL;CARREL, FRANCK;REEL/FRAME:056042/0232 Effective date: 20160401 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION COUNTED, NOT YET MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |